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Salmonella can reside in healthy animals without the manifestation of any adverse
effects on the carrier. If raw products of animal origin are not handled properly during
processing or cooked to a proper temperature during preparation, salmonellosis can
occur. In this research, microbial aspects related to Salmonella as a food pathogen are
investigated. A bioluminescent reporting system was developed for Salmonella to
monitor the attachment and growth of the pathogen on food products. Twelve and eleven
Salmonella strains from the broiler production continuum were tagged with
bioluminescence by plasmid and integration of the lux operon into the chromosome,
respectively. To assess the usefulness of bioluminescent Salmonella strains in food safety
studies, an attachment model using chicken skin was developed. Variables including
washing and temperature were tested in the attachment model to determine the effects on
attachment of Salmonella strains to chicken skin, a characteristic that enhances
persistence during processing. Additionally, the invasion process for two serovars of
Salmonella with differing host tropism was examined with emphasis on the initial

establishment of the bacterium in the host. The major facilitator for invasion, type III
secretion system, was inactivated through deletion mutation to evaluate invasion of
human epithelial cell line by additional means. The difference in host tropism between
the two subspecies of Salmonella was also taken into account when evaluating invasion.
Results showed that invasion of human epithelial cells can be initiated despite
inactivation of the type III secretion system. A serovar of Salmonella that is not typically
associated with human illness was also shown to initiate invasion of human epithelial
cells, a result that carries public health implication as this serovar has recently been
shown to be multi-drug resistant.
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CHAPTER I
INTRODUCTION

Enteritis salmonellosis is a continuing foodborne infectious disease for humans
stemming from the commercial food-animal industry in the United States. The causative
agent, non-typhoidal Salmonella, consists of more than 2,500 serotypes and is able to
reside within warm-blooded and cold-blooded animals, and in the environment.
However, only a small proportion of the serotypes (approximately 20) causes most
human infections and are usually associated with specific animal reservoirs. A significant
reservoir of this bacterium in the commercial food-animal industry is poultry. Salmonella
is able to colonize the gastrointestinal tracts of poultry without causing the host detriment
or to display symptoms of infection. However, if the bacterium is able to reach certain
numbers within the host, it can cross the pathogenic threshold and cause illness.
Typically, moribund animals are culled before they reach slaughter. More often than not
though, Salmonella is introduced into the processing plant in healthy, asymptomatic
animals. During the slaughter process, there is increased risk of cross-contamination
occurring between contaminated carcasses and previously uncontaminated carcasses. A
significant increase between the number of Salmonella positive broilers entering and then
exiting the scalding water immersion tank and exiting the crop extractor demonstrate how
in-plant cross-contamination can occur [1, 2].
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The health risk of Salmonella to humans is that the pathogen is zoonotic and in
typical instances, the bacterium is transferred from non-human to human through
ingestion of contaminated food or water. Each serotype associates with its specific host
which causes the design of a uniform strategy to control this pathogen nearly impossible.
According to FoodNet 2011 data, minimal progress has been made in reducing infections
caused by Salmonella [3]. In 2011, non-typhoidal Salmonella was the second leading
cause of domestically acquired foodborne illness in the United States, yet resulted in the
highest incidence of hospitalizations and illness resulting in death [4]. This current study
presents a novel reporter system in field-isolated Salmonella that extrapolates on existing
bioluminescent techniques. In response to limitations of the initial design of this reporter
system, the design underwent development and the re-engineering is outlined in this
study. Application of the reporter system as a screening assay in food-animal processing
is demonstrated in real-time evaluation of mitigation strategies against Salmonellacontaminated poultry skin. Further analysis in this study focused on invasion mechanisms
of Salmonella enterica serovar Typhimurium and serovar Kentucky, an internationally
emerging serotype with multi-drug resistant (MDR) consequence.
Background of the Problem
When analyzing the efficacy of various antimicrobial therapies, traditional
methodology to collect data involved conventional microbiological cultural techniques to
detect and enumerate pathogens. In this manner, after the pathogen-host relationship is
established, treatment is applied, the product is sampled, microbiological culturing
protocols are followed, and 48 to 72 hours later the results are known. In certain
instances, analysis of pathogen survival requires cell removal, and often lysis, to detect
2

the pathogen post-treatment. Collection of biological information in the context of intact
host cells is difficult to obtain without destroying the host matrix. The destruction of host
cells inhibits successive temporal data readings on a single sample, necessitating a larger
number of samples. This limitation may become problematic in experimental designs in
which resources and time are limited.
Bioluminescence is a naturally occurring enzymatic reaction that occurs in a
number of organisms from a variety of different genera [5, 6]. In the bacterium
Photorhabdus luminescens, the luciferase enzyme catalyzes the reduction of its substrate
(commonly known as luciferin) in the presence of oxygen to produce light [7].
Bioluminescent photons emitted can be detected and quantified externally using sensitive
photon detectors, like a bioluminometer. Due to the requirement of reducing power for
the reaction to occur, this biological process is exclusive to only viable bacteria. The
unique properties of this reaction are extremely attractive for the design of a
nondestructive, real-time assay to detect pathogens and monitor their survival, and as a
tool with the potential to impact antimicrobial therapy studies.
The type III secretion system (T3SS) is a specialized multi-protein complex that
functions to facilitate the transfer of proteins, termed effectors, from the cytosol of the
bacterium into the cytoplasm of the host cell [8]. Upon delivery into the host cell,
effectors manipulate host cell biology, such as cell signaling, secretory trafficking,
cytoskeletal dynamics, and the inflammatory response. The T3SS is characterized as
having three main structural components: a basal body, a multi-ring system, and needlelike apparatus; all have been similarly identified in Gram-negative bacteria, including
Salmonella, Escherichia, Shigella, Yersinia, and Pseudomonas [8]. In the context of
3

Salmonella pathology, the T3SS is reported to aide bacterium translocation across the
gastrointestinal epithelial barrier by inducing phagocytosis in non-phagocytic cells [9].
Recent scientific literature suggests a shift in the paradigm concerning the essentiality of
the T3SS function to transcending the gastrointestinal epithelial barrier [10-12], alluding
to the possibility of Salmonella to initiate phagocytosis independently of T3SS. As
internalization in non-phagocytic cells is central to the pathogenesis of Salmonella,
especially in relation to the maturation of infection, it is certainly viable that redundant
mechanisms exist with an overlapping function to preserve the invasion process. Further
experimentation would provide valuable information about these invasion mechanisms.
An increasingly comprehensive understanding of such mechanisms would be extremely
beneficial to the development of next-generation antimicrobial therapies; a direction of
research that is gaining attention as the incidence of foodborne illnesses associated with
MDR pathogens rises.
Statement of the Problem
A need exists for the development of reporter system technology in S. enterica
serotypes associated with poultry contamination that is able to circumvent the limitations
of traditional culture methodologies, while simultaneously expressing efficient and
precise data in a timely manner. In this instance, an ideal system would be able to
generate data in real-time without causing destruction of the host.
The invasion of the gastrointestinal tract is central to the pathology of Salmonella.
Recent scientific literature suggests invasion of non-phagocytic cells can occur
independently of T3SS. A gap in the knowledge exists describing the mechanisms
facilitating invasion in this manner. Additionally, insufficient attention has been aimed to
4

elucidate the molecular differences existing between nonpathogenic and pathogenic
serotypes of Salmonella that account for discrepancy of invasion rates of humans
Purpose of the Study
The purpose of this study is to establish and characterize a bioluminescence
reporting system in S. enterica using serotypes isolated from the poultry processing
continuum. The sensitivity of the reporting system will be determined by estimating the
theoretical photon emission from a single bacterium using plate counts and a
bioluminometer. Characterization of the reporting system will also take into account the
stability of the lux construct within each serotype.
A quantitative study will be performed with S. enterica serovars Kentucky and
Typhimurium and corresponding strains carrying a knockout mutation of the T3SS
complex. Each serotype and strain will be evaluated for their ability to invade a human
colorectal adenocarcinoma cell line and two types of comparisons will be conducted: 1)
between wild-type and the corresponding mutant strain and 2) between serovars
Kentucky and Typhimurium.
Significance of the Study
This research is focused in the direction of enhancing food security, contributing
to the ability of the food animal industry to meet regulations and standards thus
maintaining integrity in the food supply. Salmonella is a problematic pathogen for the
poultry industry and the Centers for Disease Control (CDC) estimates that Salmonella
contamination of poultry causes illness in 1.4 million people each year in the United
States with about 400 deaths [4]. U.S. Department of Agriculture's (USDA) Food Safety
5

and Inspection Service (FSIS) report “Analysis of ALLRTE and RTE001 Sampling
Results for Salmonella Species, Calendar Years 2005 through 2008” indicated that
prevalence of Salmonella-positive samples from the ALLRTE and RTE001 sampling
programs were < 1% for the random testing program (ALLRTE) and < 1% for the riskbased testing program (RTE001) [13].
This research is of economic importance to the state of Mississippi. The poultry
industry is the largest income-producing agricultural commodity in Mississippi’s
economy, as the poultry sector exceeded $2.7 billion in sales at the farm gate in 2012 and
total sales of poultry products by Mississippi processors exceeded $2.8 billion in 2010
[14] and employing greater than 28,000 people directly [14].
The rationale is to develop a reporting system capable of precise, quick pathogen
detection that can potentially screen mitigation strategies focused against food-animal
pathogens with minimal time constraints. Understanding the invasion mechanisms that
enable the pathogen to enter the animal host is critical to our knowledge of the pathology
of Salmonella, most certainly in the development of strategies to prevent and treat
contamination.
Primary Research Questions
There are two primary research questions that were the motivation for this
research. The first primary research question postulates whether bioluminescence can be
established within S. enterica serotypes in a stable manner. Furthermore, will the
bioluminescence be suitable for experimental use, and display sensitivity that will be able
to identify significant changes in viable bacteria numbers.
6

The second primary research question addressed facets of invasion by Salmonella
and is divided into two components. The first phase was focused on invasion of nonphagocytic cells in a fashion independent of T3SS. The null hypothesis states there is no
significant difference between invasion rates of the wild-type and the corresponding
mutant strain. The alternative hypothesis states that a significant difference does exist
between invasion rates of the wild-type and the corresponding mutant strain. The second
phase of the primary research question examines the invasion ability of a nonpathogenic
(S. enterica serovar Kentucky) and pathogenic (S. enterica serovar Typhimurium)
serotype. The null hypothesis states there is no significant difference between invasion
rates of nonpathogenic and pathogenic serotypes. The alternative hypothesis states there
is a significant difference between invasion rates of nonpathogenic and pathogenic
serotypes.
Research Design
A brief summary of the methodologies that were used in this research follows.
Salmonella serotypes for this study were field-isolated serotypes from the poultry
processing continuum. The instrumentation that was used to measure bioluminescence
intensity was an IVIS Imaging System 100 series coupled with Living Image Software
v2.50. Plasmid pAKlux1 harbors a construct of the lux operon and Salmonella serotypes
were transformed with the plasmid using standard artificial competence and
electroporation procedures. Separate experiments were conducted to characterize the lux
operon in each serotype. The reporting system was evaluated for stability and the
minimal detection limit. The development of an attachment assay with chicken skin was
described to demonstrate the application of the bioluminescence reporting system.
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The next stage of this research explored the possible establishment of a
permanently stable expression model for the lux construct. Plasmid pBEN276 encodes
the unique properties of Tn7 transposon and the lux operon. Salmonella serotypes were
transformed using pBEN276 by electroporation, and the lux operon were inserted into a
specific noncoding region of genome by the Tn7 transposon. This version of the reporting
system was characterized for stability and the minimum detection limit for each serotype.
The performance of the reporting system was challenged in two assays simulating
conditions and treatments similar to the poultry processing continuum.
The final phase of research was dedicated to the invasion process specific for
Salmonella. This section focused on nonpathogenic S. enterica serovar Kentucky and
pathogenic S. enterica serovar Typhimurium. Colorectal adenocarcinoma cell line HTB37 was targeted for invasion and was maintained according to standard procedures.
Mutations occurring within the T3SS operon in Salmonella Pathogenicity Island-1 (SPI1)
were constructed using a PCR product designed to inactivate chromosomal genes. A
standard gentamicin protection assay was used to determine invasion rates of the wildtype and the corresponding mutant strain.
Definition of Terms
In this study nonpathogenic refers to a serotype that is not traditionally known to
infect humans.
Summary
In the introductory chapter, background information concerning Salmonella as a
health-risk associated food borne pathogen was outlined. The research was introduced in
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the context of limitations associated with traditional cultivation technique for S. enterica
species. The introduction of the research progressed to discuss invasion methods
pertinent in the gastrointestinal tract. In the following chapter, key scientific concepts
related to this research will be briefly explored in the literature review, further framing
the scope of this study.
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CHAPTER II
LITERATURE REVIEW

Review of Bacterial Luciferase
A wide range of biological sensors has been used to monitor gene expression [1517]. The application of these biosensors often involves an endpoint determination of the
activity of a reporter enzyme, with samples taken at intervals for evaluation of activity in
assays requiring additional reagents. Although these methods are often sensitive and
reasonably rapid, limitations exist in that they are typically invasive and destructive and
have to be performed off-line. As such, they do not act as real-time reporters.
Bioluminescent reporters offer the ability to quantify gene expression at high sensitivity
over a large dynamic range in real-time and non-destructively.
Bioluminescent organisms are widely distributed in nature and comprise a diverse
set of species including bacteria, dinoflagellates, fungi, fish, insects, shrimp, and squid
[18-20]. The enzymes that catalyze the bioluminescence reactions within these organisms
are called luciferases. Significant differences exist between the bioluminescence reactions
as well as the structures of the enzymes and substrates from different organisms [21].
Bacterial luciferases from Photorhabdus luminescens, and other species such as Vibrio
harveyi and Xenorhabdus luminescens, have been cloned and their chemistries
characterized [7]. These bacteria use luciferase to synthesize and degrade aldehydes
10

along with the oxidation of flavin mononucleotide in the presence of oxygen that results
in the subsequent emission of light. The reaction is as follows:

Figure 2.1

Luciferase reaction

The bioreaction catalyzed by luciferase resulting in the production of bioluminescent
light.
The reaction is highly specific for FMNH2. Modification of the flavin ring or
removal of the phosphate group decreases the activity significantly [22]. Thus, the
requirement of reducing power (FMNH2) by the reaction implicates the measurement of
lux gene activity as a means to monitoring metabolic activity.
The lux operon in P. luminescens consists of five genes, luxCDABE (Figure 2.2).
Bacterial luciferase is a heterodimeric enzyme composed of α and β subunits which are
encoded by luxA and luxB. Studies have shown that the α subunit almost exclusively
controls substrate specificity and turnover rate of the enzyme [23]. The synthesis of
aldehyde substrate for the bioluminescence reaction is catalyzed by a multi-enzyme fatty
acid reductase complex containing three proteins, a reductase, a transferase, and a
synthetase [24, 25]. These three polypeptides are encoded by luxC, luxD, and luxE,
respectively. In brief, the transferase subunit catalyzes the transfer of activated fatty acyl
group to water as well as other oxygen and thiol acceptors, creating the substrate for the
following reaction catalyzed by the fatty acid reductase. The reductase and synthetase
components make up the fatty acid reductase complex which catalyzes the reduction of
11

fatty acids to aldehydes. The synthetase activates the fatty acid by creating a fatty acylAMP intermediate. In the presence of the reductase, the acyl group is reduced by
NADPH to aldehyde [26]. All the components of the fatty acid reductase complex are
specifically acylated during the enzyme reaction. Each subunit has been identified in vivo
or in extracts by labeling with radioactive fatty acids [27].

Figure 2.2

The lux operon.

The gene arrangements and direction of gene expression on the luxCDABE operon
The bioluminescence reaction does place an additional energy burden upon the
cell and therefore may limit the scope of studies under certain environmental conditions,
in which adequate energy reserves are not available. As is the case with sufficient energy
reserves, sufficient O2 is a requirement for the bioluminescence reaction to occur.
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Luciferase as a Rapid Screening Method
Luciferase has been shown to be a versatile tool to provide in vivo indication of
cell localization and biological function. Emitted light from the luciferase reaction can be
detected externally using sensitive photon detectors such as cooled integrating chargecoupled device (CCD) cameras to create bioluminescence images [28]. Light emission
can then be measured with software designed specifically for in vivo applications.
Bioluminescence imaging (BLI) has been applied to pathogen detection [29], tumor
growth and response to therapy [30], patterns of gene regulation [31], and measurements
of protein-protein interactions [32]. Since the initial demonstration of the expression of
lux in S. Typhimurium [33], many bacterial strains have been engineered to track the
course of an infection [34] or monitor the efficacy of antimicrobial therapies. The lux
operon from P. luminescens has been transferred into indicator strains S. aureus, E. coli,
and S. Typhimurium and used in an assay to demonstrate the well-documented effects of
antimicrobial compounds tetracycline and nisin with EDTA on bacteria metabolism and
viability [35]. The nature of tetracycline and nisin/EDTA is to disrupt protein synthesis
and cell membrane integrity, respectively; causing destruction of the cell. For all
indicator strains imaging indicated reduced bioluminescence, which paralleled reduced
number of culturable cells. From these results, it was concluded that the effect of
antimicrobial substances on the indicator strains can be detected earlier as reduced
bioluminescence compared to standard plate counting and overnight incubation.
Additional applications of BLI include monitoring biological processes, such as
the study of the biofilm forming-pathogen S. aureus in implanted medical devices [36],
as well as identifying the unexpected extracellular replication of L. monocytogenes in the
13

gall bladder lumen of mice [37]. In other instances, the lux operon was constructed to be
induced under an appropriate promoter, such as iNOS (inducible nitrous oxide synthase
gene) or NF-κB promoter, to monitor gene expression levels in animals [38-40].
Literature shows that traditional protocols can be supplemented with luciferase as a
reporter gene in order to monitor gene expression or detect pathogens non-invasively
through the course of infection, and in real time, to increase our understanding of the
infectious disease processes, the underlying mechanisms of pathogenesis, and the host
response to the disease. Currently, expression of the lux operon has been expressed in a
narrow range of Salmonella species. This research aimed to expand the scope of
luciferase reporter technology to include the most prevalent serotypes of Salmonella in
the poultry processing continuum.
Review of Tn7 Transposon
Transposition is a unique process that involves the movement of genetic elements
between non-homologous positions within genomes. Tn7 transposon is a rapid and
reliable system for transposition that is distinguished by its ability to recognize and insert
with high efficiency and unique orientation at specific site attTn7 [41, 42]. This site of
insertion is located just downstream of the coding region, in the transcriptional
terminator, of the highly conserved chromosomal glmS gene [43]. The glmS gene encodes
a glucosamine synthetase, which is required for cell wall synthesis [44]. Insertion does
not disrupt the glmS open reading frame and causes no obvious fitness costs to the host
[45]. Because the glmS gene is conserved among many bacteria, Tn7 is likely to have the
same specific insertion site in many different bacteria [41, 46-53].
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Transposition is a process that is tightly regulated by the recognition of the target
site and assembly of a TnsABC+D transposome from four transposon-encoded
polypeptides: TnsA, TnsB, TnsC, and TnsD. Excision of Tn7 from the donor site does
not occur unless attTn7 and all the Tns proteins are present and site specific insertion
does not occur without all four Tn7-encoded proteins [54]. Briefly, element-encoded
transposases bind specifically to transposon ends and mediate the catalytic steps in
transposition, cleaving the phosphodiester bonds that link the transposon to the donor site
and joining the transposon ends to the insertion site [55-57]. TnsD binds to its 30-bp
binding site at the end of the highly conserved glmS gene, which generates distortions in
the DNA [54, 58]. TnsC is recruited to this distorted DNA [59]. The interaction of TnsC
with TnsD-attTn7 leads to the regulation of transposase activity via TnsC interactions
with both TnsA and TnsB [60-63]. TnsA and TnsB form the transposase that carries out
Tn7 DNA breakage and joining [64-66] and is controlled by interaction of TnsAB with
TnsCD bound to attTn7 [54].
Review of Salmonella Prevalence
Salmonella enterica infections are a significant public health concern globally,
accounting for approximately 1 million cases, 19,000 hospitalizations, and nearly 400
deaths in the United States each year [4]. Human salmonellosis is typically associated
with the consumption of contaminated foods, such as fresh and processed meat and
poultry, eggs, and fresh produce [67]. The potential risk for exposure to Salmonella
through contaminated food products is greater due to the increase in poultry consumption
in the United States, and the subsequent growth of the commercial poultry sector in the
animal agricultural industry. While strides have been made to limit the prevalence and
15

frequency of Salmonella contamination in processed poultry, there is rising pressure on
the commercial poultry industry to prevent and/or eliminate these pathogens during preharvest production. Pre-harvest is a critical stage for intervention due to the susceptibility
of young birds to Salmonella colonization of the gastrointestinal tract by vertical
transmission from infected parents or by horizontal transmission at the hatcheries during
feeding, handling, and transportation [68, 69].
Review of Salmonella Pathology
Salmonella can colonize birds through fecal-oral transmission [70, 71]; however,
in newly hatched chicks, colonization can also take place via the nose or cloaca [72].
These bacteria can pass through the gastrointestinal tract of the birds, in which
Salmonella can express acid shock proteins (RpoS σ-factor, PhoPQ, and Fur) for survival
at a low gastrointestinal pH and exposure to short-chain fatty acids in the poultry gut [73,
74]. Salmonella can colonize the intestinal area through several genetic changes, such as
the expression of fimbria-associated proteins (Fim, Lpf, and Pef) [75-77] and genes
encoding fimbrial types SEF17 and SEF21 [78] to facilitate adhesion of the bacteria to
the host intestinal cell surface. Salmonella can then multiply and invade the intestinal
mucosa, cecal tonsils, and Peyer’s patches, survive and multiply in macrophages, spread
to the liver and spleen via the bloodstream or lymphatic system, and eventually infect
other organ systems (ovary, oviduct, gizzard, yolk sac, or lungs) [70, 74, 79]. The
environment can become contaminated due to the excretion of the bacteria through feces.
Vertical transmission of Salmonella has been reported in infected ovaries, oviducts, or
infected eggs; these infections may be asymptomatic in adult birds [70].
16

Review of Salmonella-Host Interaction
The interaction between Salmonella and host cells has been shaped by intimate
coexistence, leading to a rather balanced interaction that allows bacterial replication
while preventing excessive harm unless the host is compromised. The various serotypes
of S. enterica cause different diseases, ranging from self-limiting gastroenteritis to a
systemic illness such as typhoid fever. Central to the pathogenesis of Salmonella is the
invasion of the gastrointestinal epithelium tissue. To accomplish this task, the bacteria
have evolved virulence traits to adapt with their host that enables the organisms to induce
their own internalization by non-phagocytic cells to successfully survive and replicate
intracellularly [80]. The most extensively studied mechanism of invasion involves a
multi-protein complex termed the type III secretion system (T3SS). Until recently, it was
accepted that Salmonella invasion of eukaryotic cells required only T3SS encoded in the
Salmonella Pathogenicity Island-1 (SPI1). However, recent studies have shown that
Salmonella can cause infection in a manner independent of T3SS [11, 81]. This data
sheds light on a new paradigm that slightly contrasts with traditional understanding, and
lends itself to the possibility of unknown entry routes that may be specific to the serotype,
the host, and the cell type considered, potentially affecting the outcome of different
Salmonella-induced diseases.
Type III Secretion System
Many plant and animal bacterial pathogens assemble a complex needle-like
nanomachine termed T3SS to translocate effector proteins from the cytoplasm of the
bacteria into the cytosol of the host eukaryotic cell in order to initiate infection by
activating or altering cellular processes [9]. The ability of bacteria to inject effectors into
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host cells is essential for infection, survival, and pathogenesis of many Gram-negative
bacteria, including Escherichia [82], Shigella [83], Yersinia [84], Pseudomonas [85], and
Chlamydia spp [86]. The structural genes, effector genes, and transcriptional regulators
unique to Salmonella are clustered in one region of the genome, SPI1 (Figure 2.3). The
gene cluster is theorized to have been acquired by one or more horizontal transfer events
during its evolution [87]. Support for this theory stems from the deviating GC base
content of the pathogenicity island from that of its chromosome and artifacts of
transposable elements that flank the region [87].

Figure 2.3

Orientation of Salmonella Pathogenicity Island-1

The genes encoding structural proteins are denoted as grey, the genes encoding effectors
are denoted as white, and the genes that encode transcriptional regulators are denoted as
black.
Emergence of Alternate Mechanisms of Entry
Salmonella entry into host cells strictly depends on the function of the actin
cytoskeleton as addition of drugs that interfere with actin dynamics effectively block
bacterial internalization [88]. An emerging perspective on Salmonella speculates
infection of gastrointestinal epithelium cells may occur through multiple pathways, which
contrasts with the traditional essential role of T3SS to bacterial invasion of host cells.
Although numerous studies demonstrate a role of type III secretion in host infection,
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recent studies using bovine, chicken, murine, and human models to determine the
function of SPI1 suggests Salmonella is able to cause infection in a manner independent
T3SS [10, 11, 81, 89]. Radtke et al. demonstrated S. enterica serovar Typhimurium was
capable of active invasion of a 3-D model of human colonic epithelium cells without the
expression of T3SS genes [10]. Desin et al. observed a S. enterica serovar Enteritidis
strain mutated for SPI1 expression displayed invasion of polarized human intestinal
epithelial cells (Caco-2) and chicken intestinal tissue explants in a reduced capacity in
comparison to the wild-type strain [89]. The same study orally challenged 1-week-old
chicks with the wild-type or SPI1 mutant strain and no difference in cecal colonization
was observed, suggesting infection mechanisms correspond with chicken maturity and
infection in this situation may not be exclusive to T3SS [89]. Similar findings were
observed by Morgan et al., in which disruption of T3SS caused only minor reduction in S.
enterica serovar Typhimurium colonization of chicks [90]. The type of interaction
between Salmonella and its host leading to infection is sophisticated and dynamic,
dependent on the serovar, cell-type considered, and host; and support from scientific
literature suggests additional mechanisms may act in a complementary role to T3SS to
facilitate and modify the initiation of eukaryotic cell entry [91, 92].
Emergence of Salmonella Kentucky
Spanning the last several decades, there have been significant shifts in Salmonella
populations associated with poultry and human infections. Among the leading serotypes
associated with human infections over the last quarter century, the widespread prevalence
of S. enterica serovar Enteritidis among poultry developed into a significant problem in
the commercial poultry industry [93, 94] until the National Poultry Improvement Plan
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(NPIP) began targeting S. Enteritidis for eradication in eggs 1989 and in meats in 1994
[95]. The ecological niche in poultry created by the reduction of S. Enteritidis may have
been filled by S. enterica serovar Heidelberg and S. enterica serovar Kentucky due to
differences in surface antigens [96]. Initially isolated from a chick in the U.S. in 1937
[97], S. Kentucky has a close association with poultry and poultry products, and recently
has been the most frequently isolated serotype on broilers as they exit the chiller during
processing [98-101]. The practice of antibiotic use in agriculture, especially in the United
States, not only to treat and prevent disease but also to promote growth [102] may have
contributed to the ascension and dissemination of S. Kentucky. Multidrug resistant
variants of S. Kentucky have been identified at a high frequency from chickens in the
United States [103] and in Ireland [104]. Additionally, multidrug resistant variants of S.
Kentucky have been identified from human samples in France, England and Wales,
Denmark, United States, and Canada with travel from northern Africa in common [105108]
Summary
In the literature review chapter, key scientific concepts related to this study were
discussed and placed in the context of the research community, highlighting the gap in
the knowledge this current study aims to fill. Components of the lux operon were
outlined, in addition to recent applications of the luciferase gene as a biosensor in
microbiology. The details of the transposition reaction were explored as a molecular
technique to be used in this study for gene transfer. A brief overview of the T3SS was
outlined, highlighted with recent reports of possible entry methods for Salmonella that
may supplement the function of T3SS. In the conclusion of this chapter, the emergence of
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S. Kentucky in the poultry industry and as an international MDR bacterial strain among
travelers was reported in depth. The following chapter will encompass the research
devoted to the establishment of the plasmid-based lux operon as a reporter system in
field-isolated Salmonella serotypes.
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CHAPTER III
DEVELOPMENT OF PLASMID-BASED REPORTER SYSTEM FOR
SALMONELLA ENTERICA

In this chapter, the aim was to develop twelve bioluminescent S. enterica
serotypes that can be used for real-time monitoring of the pathogen’s growth on food
products. This study is unique in that it includes multiple Salmonella field-isolated
serotypes from the broiler production continuum, including post hatchery, prior to
harvest, arrival at the plant, pre-chill tank, and post-chill tank. This chapter also outlines
the development of the protocol for a novel assay that can quickly and precisely quantify
viable bacteria numbers present on chicken skin that has potential application as a tool to
evaluate various mitigation strategies.

*The following chapter has been submitted for publication and is published in the open
access journal BMC Microbiology.
Karsi A, Howe K, Kirkpatrick TB, Wills R, Bailey RH, Lawrence ML: Development of
bioluminescent Salmonella strains for use in food safety. BMC Microbiol 2008,
8:10.
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Methodology
Bacterial Serotypes and Growth Media
As part of a previous study, thousands of Salmonella specimens derived and
catalogued from five different sites along the broiler production continuum: posthatchery, prior to harvest, arrival at the plant, pre-chill tank and post-chill tank were
collected, isolated, and serotyped [109]. Salmonella isolates were collected from 66
different flocks during the years 2003-2006. The catalogued information ascribed to each
isolate includes: location within the production continuum, flock environmental and
production parameters, and processing plant information. The twelve most commonly
isolated S. enterica serotypes from the poultry production continuum were selected for
the following study (S. Alachua, S. Braenderup, S. Enteritidis, S. Heidelberg, S.
Kentucky, S. Mbandaka, S. Montevideo, S. Newport, S. Schwarzengrund, S. Senftenberg,
S. Thompson, and S. Typhimurium). S. enterica serotypes were cultured in Luria-Bertani
(LB) media and agar plates at 37°C. Plasmid selection was conducted in media
supplemented with ampicillin (Amp) (100 µg/mL).
Bioluminescence Tagging of Salmonella enterica with Plasmid pAKlux1
Bioluminescent Salmonella enterica serotypes were established using broad host
range plasmid pAKlux1 [110] (Figure 3.1). Plasmid pAKlux1 contains the luxCDABE
operon cloned from P. luminescens (Meighen, 1991). Bacterial concentration was
determined by optical density values at wavelength 600 nm (OD600) using GENESYS 20
Visible Spectrophotometer (Thermo Fisher Scientific, Waltham, MA). S. enterica
serotypes was grown to logarithmic phase (OD600 = 0.6-0.8) in preparation of washing
with 10% v/v cold glycerol solution (4x) to create electrocompetent cells. Cells were
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stored at -80°C until transformation. Plasmid pAKlux1 was prepared from Escherichia
coli DH5α strain using Qiagen QIAprep Spin Miniprep Kit (Qiagen, Valencia, CA).
Transformation of Salmonella enterica serotypes with plasmid pAKlux1 was conducted
by electroporation using Gene Pulser II System with parameters 2.5 kV, 25 µF, and 400
Ω (Bio-Rad, Hercules, CA). Cells recovered in S.O.C. media (Invitrogen Corp., Carlsbad,
CA) at 37°C for 1 h. Following recovery, bacteria suspensions were spread on LB + Amp
agar to incubate at 37°C for approximately 16 h to select for successful transformations.
Colonies displaying Amp resistance were tested for bioluminescence production using
ChemiImager 5500 Imaging System integrated with AlphaEaseFC Software (Alpha
Innotech, San Leandro, CA) or IVIS Imaging System 100 Series integrated with Living
Image Software v2.50 (Xenogen Corp., Alameda, CA).
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Figure 3.1

Physical map of the broad host range plasmid pAKlux1

A 6.9-kb EcoRI fragment carrying the lux operon cloned from P. luminescens is oriented
such that the operon is transcribed from Plac.

Characterizing Bioluminescence Properties of Plasmid-Based Luciferase Reporter
System
Bioluminescent S. enterica serotypes maintaining plasmid pAKlux1 were grown
to stationary phase and confirmed with OD600 values measured with Thermomax
Spectrometer (Molecular Devices, Sunnyvale, USA). Serotypes were arranged as
quadruplicate samples in black clear-bottom 96-well microtiter plate (Costar). A dilution
series was prepared for each sample. Each series contained 2 x 10-3, 4 x 10-3, 8 x 10-3, 1.6
x 10-4, 3.2 x 10-4 6.4 x 10-4, 1.3 x 10-5, and 2.6 x 10-5 dilutions. Bioluminescence was
measured with IVIS Imaging System 100 Series with 5 s exposure at 37°C and quantified
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using Living Image Software v2.60. Bioluminescence was normalized by dividing total
flux by OD600 readings. Minimum detectable bacterial densities were determined from
the last two dilutions using plate counts on LB + Amp agar.
Linear correlation formulas were calculated for each serotype using
bioluminescence values and bacteria population numbers determined by duplicate plate
counts. The minimum detectible number for each serotype was identified using the
number of bacteria present in the last dilution that displayed detectable bioluminescence
above background. Colony counts aided in calculation of the theoretical amount of
bioluminescence produced per colony forming-unit (CFU) for each serotype.
Stability of Plasmid pAKlux1 in Salmonella enterica
Stability of plasmid pAKlux1 in S. enterica serotypes was assessed by
subculturing the twelve S. enterica serotypes with plasmid pAKlux1 in LB media with
and without Amp for selection for a period of 15 d. For each passage, fresh 0.1 mL
cultures were inoculated at a 40-fold dilution in black clear-bottom 96-well microtiter
plate in quadruplicate from overnight cultures. Bacterial density (OD600) and
bioluminescence were determined for each of the overnight cultures prior to starting the
next round of inoculations. Bioluminescence was measured using IVIS Imaging System
with exposure time 5 s at 37°C and normalized by dividing total flux by OD600 readings.
The average normalized bioluminescence for each serotype and passage was determined
under non-selective and selective conditions. Plasmid stability was determined by
calculating the ratio between normalized bioluminescence under non-selective conditions
and selective conditions. This ratio revealed the half-life of plasmid pAKlux1 under nonselective conditions in each serotype.
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Development of Skin Attachment Model
The protocol for an experimental model to investigate bacterial attachment to
chicken skin is outlined as follows. Chicken skin obtained from a Mississippi commercial
poultry processing plant was submerged in 0.26% sodium hypochlorite solution for
approximately 2 h and stored at 4°C until use. Circular sections, approximately 8 mm in
diameter of chicken skin were made using a circular cutting blade and placed in black
clear-bottom 24-well tissue plate (Wallac). In previous work to determine the optimal
bacterial dose to prevent loss of experimental data due to image saturation, chicken skin
was incubated with different numbers of bioluminescent Salmonella (1 x 108 - 2.5 x 104
CFU) in 1 mL of phosphate-buffered saline (PBS). Based on these results (data not
shown), a bacterial concentration of 1 x 106 CFU/mL was used for subsequent
experiments to avoid saturation.
Characterization of Skin Attachment Properties of Salmonella enterica
The skin attachment model was constructed with the bioluminescent S. enterica
serotypes to develop a quick and precise method to determine differential attachment
properties. Fresh bacterial culture was diluted to approximately 1 x 106 CFU/mL in
sterilized distilled water, and 1 mL was inoculated on skin sections. Quadruplicates for
each serotype were arranged in black clear-bottom 24-well tissue plate. After inoculation,
cultures incubated at room temperature for 1 h to allow bacteria to attach to the skin.
Following incubation superfluous bacterial suspension was vacuum removed and each
well gently washed with sterilized distilled water. This process was repeated twice to
extract unattached bacteria. Plates were immediately warmed to 37°C for 5 m and
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bioluminescence was quantified using IVIS Imaging System with exposure time 15 s.
The experiment was repeated three times.
Total flux was calculated from the pseudo color images produced by the IVIS
Imaging System. To normalize for bacterial density differences between serotypes, the
total flux from each well was divided by OD600 of the initial bacterial suspension used to
inoculate that well. Due to variance of bioluminescence among the different serotypes,
theoretical numbers were calculated from bioluminescence using the linear correlation
formulas calculated for each serotype. The data was transformed by taking the base 10
logarithm of the calculated bacterial numbers to improve normality. Statistics on the
transformed data of the bacterial numbers were calculated by a two-way analysis of
variance (ANOVA) using PROC GLM SAS 9.1 (SAS Institute Inc., Carey, NC).
Variables for this model included replicate, serotype, and their interaction. Pairwise
comparison of the means was conducted using Tukey procedure. A significance level of
P ≤ 0.05 was used for all statistical purposes. Data was then retransformed to percent
mortality for interpretation.
Salmonella enterica Removal from Chicken Skin by Washing
During traditional poultry processing, a component in microbial removal from the
carcasses includes chlorine hydration treatment in the forms of carcass cabinet washers,
immersion chillers, or equipment sprays [111-113]. A simulation of these parameters was
constructed using our skin attachment model in order to design a laboratory assay for
various experimental treatments with quick and simple interpretation of results that
operates under actual poultry processing conditions. Samples of our twelve
bioluminescent S. enterica serotypes were incubated with chicken skin sections as
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described for the skin attachment model. The non-washed skin acted as the control group
and the washed skin as the treatment group. Following the 1 h incubation period and
wash and vacuum to extract superfluous bacteria, the assay plate was warmed to 37°C for
5 m in preparation for bioluminescence imaging. Each treatment well containing
microbial contaminated poultry skin received 1 mL of sterilized distilled water. Assay
plates were subjected to repeated series of incubations at room temperature (25°C) for 30
m with agitation at 200 rpm followed by water removal by vacuum. Bioluminescence
was measured from the pseudo color images of the chicken skin to quantify bacterial
presence. One mL of sterilized distilled water was added to the treatment group to begin
the next round of washing until a total of 2 h washing had been completed. The groups
were set up in quadruplicate and the results were collected from three separate trials.
Total flux values were normalized as described previously in the skin attachment model.
The difference between the initial total flux of the samples before treatment (0 m)
from the final total flux after treatment (120 m) was calculated to determine the
accumulative effect all of the washes had on microbial removal from the surface of
chicken skin. The difference value was averaged among the quadruplicates over the three
trials to produce a mean difference value for each serotype. The mean difference for a
serotype of the washed group was compared to its counterpoint in the non-washed group
by ANOVA using PROC GLM SAS 9.1 to evaluate the effectiveness of washes to
remove Salmonella from poultry skin. Variables in this model included replicate,
treatment, and their interaction. The mean difference value was compared across
serotypes with ANOVA using PROC GLM SAS 9.1 to determine the relevant degree of
microbial removal due to washes. Variables for this model included replicate, serotype,
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and their interaction. Pairwise comparison of the means was also conducted using Tukey
procedure. A significance level of P ≤ 0.05 was applied in all statistical analyses.
Results and Discussion
Characterizing Bioluminescence Properties of Plasmid-Based Luciferase Reporter
System
Plasmid pAKlux1 was transferred to twelve S. enterica serotypes that were
isolated from the poultry production and processing continuum [109]. The serotypes
represented the twelve most commonly isolated serotypes from the study. This result
compared favorably with a previous report where transformation of a lux plasmid into
Salmonella isolated from a poultry processing plant was only successful for one isolate
out of seven attempted [114]. Expression of the luxCDABE operon, which encodes
bacterial luciferase, was driven by the lacZ promoter on pAKlux1. Because Salmonella
does not have lacIq in its chromosome, it constitutively expresses the lacZ promoter on
pAKlux1 and hence produces continuous light while it is alive and metabolically active.
We showed that bacteria numbers and bioluminescence correlated well (R2 =
0.99) in all serotypes used (Figure 3.2). The minimum detectable numbers for all twelve
serotypes was less than 1500 CFU/mL and it was less than 300 CFU/mL for a majority of
serotypes: S. Alachua, 334 CFU/mL; S. Braenderup, 217 CFU/mL; S. Enteritidis, 175
CFU/mL; S. Heidelberg, 169 CFU/mL; S. Kentucky, 229 CFU/mL; S. Mbandaka, 248
CFU/mL; S. Montevideo, 209 CFU/mL; S. Newport, 125 CFU/mL; S. Schwarzengrund,
1470 CFU/mL; S. Senftenberg, 1386 CFU/mL; S. Thompson, 1044 CFU/mL; and S.
Typhimurium, 202 CFU/mL. This result was comparable to previous studies [33, 110,
115, 116].
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Figure 3.2

Correlation between bioluminescence and bacterial numbers

The correlation between bioluminescence signals and bacteria numbers for representative
serovars S. Montevideo and S. Newport.
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The average theoretical light intensity per CFU was calculated for each serotype
and revealed a greater than 10-fold difference between some serotypes (Figure 3.3). This
difference was not due to lack of viability; bacterial plate counts showed that all the
serotypes were viable at this stage and that viable bacterial densities for all the serotypes
were within a 3 fold range. The difference in bioluminescence could reflect a difference
between serotypes in efficiency of luxCDABE expression from the lacZ promoter, or it
could reflect a difference between serotypes in the activity of bacterial luciferase within
the bacteria. Alternatively, the difference could reflect differences in metabolic activity
between the serotypes at this stage of growth (16 h). Bioluminescence is known to
correlate well with bacterial metabolism [117, 118].
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Figure 3.3

Expression of bioluminescence in Salmonella enterica serotypes

The theoretical amount of bioluminescence produced per CFU of each S. enterica
serotype following 16 h of growth was calculated. Bioluminescence per CFU was
calculated by dividing the background subtracted bioluminescence value (in p/s/cm2/sr)
in each well by the number of bacteria (determined by serial dilution and plate counts).
The mean and standard error from four replicates were then determined for each serotype.
Light emission was almost 12 fold higher in S. Newport as compared to S.
Schwarzengrund
Stability of Plasmid pAKlux1 in Salmonella enterica
The stability of plasmid pAKlux1 was determined by subculturing eleven
bioluminescent S. enterica serotypes in broth cultures under selective (Amp) and nonselective conditions for 15 d. Bioluminescence of S. enterica serotypes cultured under
non-selective conditions was declining by day 2 and continued declining linearly (R2 =
0.95) until the conclusion of the experiment (Figure 3.4). Based on the data, the average
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half-life of plasmid pAKlux1 in S. enterica was approximately 7 d under the described
culture conditions. However, the stability varied between S. enterica serotypes. Among
the S. enterica serotypes, plasmid stability was lower in S. Kentucky and S. Typhimurium
as compared to the others. The half-life of plasmid pAKlux1 was about 4 d in S.
Kentucky and about 5 d in S. Typhimurium (Figure 3.4). S. Newport, S. Alachua and S.
Enteritidis maintained plasmid pAKlux1 longer than others, with a half-life of
approximately 9 d.
Plasmid pAKlux1 is derived from the broad host range plasmid pBBR1, which is
relatively stable in gram-negative bacteria in the absence of antibiotic selection [119121]. Plasmid pAKlux1 was stable in the Gram-negative species Edwardsiella ictaluri for
at least 10 d without antibiotic selection, and the plasmid caused no alterations in growth
kinetics, native plasmids and pathogenicity as compared to the parent strain [110]. Data
from the current study indicated that the plasmid pBBR1 replicon is not as stable in
Salmonella as it is in other Gram-negative bacteria.
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Figure 3.4

Stability of plasmid pAKlux1 in Salmonella enterica

S. enterica serotypes carrying pAKlux1 were subcultured under Amp selective and nonselective conditions for 15 d. At each passage, bioluminescence was measured and
normalized for cell density (OD600). The ratio between the normalized values under nonselective (nLB) and Amp selected conditions (nLBAmp) revealed the plasmid stability in
different S. enterica serotypes. The black line represents the mean of eleven serotypes,
and the red line is the linear trend line.
Characterization of Skin Attachment Properties of Salmonella enterica
We developed an in vitro skin attachment model for characterization of
attachment properties of different S. enterica serotypes using bioluminescence imaging
(BLI). Bioluminescence was successfully detected on chicken skin after being exposed to
S. enterica serotypes expressing plasmid pAKlux1. Using this model, we were able to
show that S. enterica serotypes vary in their ability to attach to chicken skin (Figure 3.5).
Bacteria numbers in S. Senftenberg, S. Thompson and S. Schwarzengrund were
significantly different from each other and from other serotypes (P ≤ 0.05). The S.
Heidelberg serotype had significantly less binding to chicken skin than all the other
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serotypes and was 79 fold lower than S. Senftenberg, which had the highest amount of
binding (Figure 3.5). This result suggests that S. enterica serotypes vary in their ability to
bind to chicken skin; this ability may be a discriminating factor determining whether
Salmonella persist through processing or whether they are removed.

Figure 3.5

Attachment of Salmonella enterica to chicken skin

The amount of Salmonella attachment to chicken skin was determined by measuring the
bioluminescence following 1 h incubation of bacterial suspension with quadruplicate skin
samples. Bacteria numbers of each serotype were estimated from the bioluminescence
values using each serotype’s linear correlation formula.
Salmonella enterica Removal from Chicken Skin by Washing
Bioluminescence was an effective tool for measuring the effects of washing for
removal of S. enterica from chicken skin using our model (Figure 3.6). Bioluminescent S.
enterica have been previously utilized to monitor progress of infection, effect of heat and
pH treatments, growth in food samples and toxicity [33, 114, 122, 123]. One study used a
single bioluminescent Salmonella enterica serovar Hadar isolate to investigate the
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effectiveness of washing for removal of Salmonella from turkey skin [114]. The current
study demonstrates to the extent of our knowledge, the first use of BLI to monitor twelve
distinct S. enterica serotypes using a chicken skin model.

37

Figure 3.6

The effect of washing on removal of Salmonella from chicken skin

Bioluminescence was used to measure the ability of an agitated water bath to remove S.
enterica serotypes from chicken skin. Salmonella was allowed to attach to chicken skin
for 1 h, and then the amount of Salmonella present on skin that received four 30 m
washes was compared to the amount of Salmonella present on non-washed skin.
Bioluminescence was measured after each 30 m wash and the mean of four replicates
from the three separate experiments was determined. A) Representative plate containing
three S. enterica serotypes at five time points. Half of the plate included washed skin
samples (w) and the other half included unwashed skin controls (nw). Column 1 is S.
Senftenberg, column 2 is S. Thompson, and column 3 is S. Typhimurium. B) Amount of
bioluminescence for the three representative serotypes at each time point.
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As a general trend observed for all serotypes, washing suppressed the
reproduction of Salmonella on chicken skin, probably due to physical removal of bacteria
(Figure 3.7). In non-washed skin samples, Salmonella numbers increased steadily over
the two hour incubation period as indicated by bioluminescence quantification (Figure
3.6B), with final flux numbers showing an increase ranging from 143% (S.
Schwarzengrund) to 459% (S. Newport) compared to initial measurement at time zero.
Washed skin samples showed a lower increase in bioluminescence at the conclusion of
the experiment compared to the non-washed skin samples, demonstrating the
effectiveness of simple agitation in water for suppressing Salmonella growth on chicken
skin.
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Figure 3.7

Comparison of the amount of Salmonella before and after 2 h incubation

The change in bioluminescence on chicken skin following 2 h incubation (relative to prewash bioluminescence) for washed and non-washed treatments is shown. Letters at the
top of the graph indicate statistical groupings for the mean differences between washed
and non-washed treatments within each serotype as determined by Tukey’s test. Values
with the same letter are not significantly different (P ≤ 0.05).
For all twelve serotypes, the washed treatments had a significantly lower change
in bioluminescence than the corresponding non-washed treatments after the 2 h wash
period. However, there was serotype variation in the effectiveness of washing (Figure
3.7). For three serotypes (S. Kentucky, S. Mbandaka and S. Montevideo), washing
reduced the number of Salmonella present on chicken skin at 120 m compared to 0 m
(pre-wash). For the other serotypes, although washing did not decrease the number of
Salmonella on chicken skin, as indicated by bioluminescence measurements, it was
effective in significantly reducing the growth relative to non-washed samples.
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When the differences in bioluminescence between washed and non-washed
treatments at 120 m were compared across serotypes, the decrease in bioluminescence for
S. Newport caused by washing was significantly greater than the decrease in
bioluminescence for S. Alachua, S. Braenderup, S. Enteritidis and S. Schwarzengrund
(Figure 3.7). Thus, based on the difference in bioluminescence between washed and nonwashed treatments, washing was observed to be most effective in removing S. Newport
and lease effective for S. Alachua, S. Braenderup, S. Enteritidis and S. Schwarzengrund.
However, it is interesting to note that the two serotypes that attached to chicken skin most
effectively (S. Senftenberg and S. Thompson; [Figure 3.5]) were also able to increase
their bioluminescence output in the wash treatment most effectively (3.7 and 2.7 fold
increases, respectively, relative to pre-wash) over the 2 h incubation period.
Summary
In this chapter, the initial version of our luciferase reporter system was established
in twelve serotypes of Salmonella isolated from the poultry processing continuum. The
minimum detectable limit was estimated for each serotype and the plasmid to have an
average half-life of 7 d without antibiotic pressure. Certain instances when antibiotic
pressure cannot be applied, length of observation must be taken into consideration when
designing experiments using plasmid pAKlux1. Bioluminescent S. enterica serotypes
labeled with plasmid pAKlux1 should be suitable for short term experiments. In vivo
experiments as well as studies with longer time courses will require a stable construct for
the reporting system. In response to this limitation, the following chapter will introduce
our research devoted to cloning the luxCDABE operon into a Tn-7 based transposon
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system that will insert the lux operon into the chromosome at a specific location and
confer stability to the lux cassette.
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CHAPTER IV
DEVELOPMENT OF CHROMOSOME-BASED REPORTER SYSTEM FOR
SALMONELLA ENTERICA

In this chapter, we aimed to develop a stable bioluminescence reporter system for
several S. enterica serotypes. We used serotypes isolated from the broiler production
continuum, including post-hatchery, prior to harvest, arrival at the plant, pre-chill tank,
and post-chill tank. Furthermore, we used these serotypes to conduct a series of
experiments to monitor cellular metabolic activity and pathogen attachment to chicken
skin under simulated processing conditions by quantifying bioluminescence from the
bacteria using a luminometer.

*The following chapter has been submitted for publication and is published in the open
access journal BMC Microbiology.
Howe K, Karsi A, Germon P, Wills R, Lawrence ML, Bailey RN: Development of
stable reporter system cloning luxCDABE genes into chromosome of
Salmonella enterica serotypes using Tn7 transposon. BMC Microbiol 2010,
10:197
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Methodology
Bacterial Serotypes and Growth Media
Eleven S. enterica serotypes from the poultry production continuum were selected
from our catalogued library of isolates for this study (S. Alachua, S. Braenderup, S.
Enteritidis, S. Heidelberg, S. Kentucky, S. Mbandaka, S. Montevideo, S. Newport, S.
Schwarzengrund, S. Senftenberg, and S. Typhimurium). S. enterica serotypes were grown
with Luria-Bertani (LB) media and agar plates at 37°C. Plasmid selection within S.
enterica was conducted in media that contains ampicillin (Amp) at concentration 100
µg/mL. LB media was supplemented with 0.1% arabinose to induce transposition when
appropriate.
Construction of Plasmid pBEN276
The luxCDABE operon was amplified from the genome of Photorhabdus
luminescens with primers PG131 (gatgctacctcgaggtacaaccagtttgcaagatg) and PG132
(tacgctcaggatccgaattcactcccttgccatc) and cloned in plasmid pCR21 (Invitrogen) to yield
plasmid pBEN139. The XhoI-BamHI restriction fragment from plasmid pBEN139 that
includes genes luxCDABE was subcloned in plasmid pBEN129, a derivative of plasmid
pACYC184 [124], into XhoI and BamHI sites to yield plasmid pBEN135. The XhoI-NotI
fragment from plasmid pBEN135 carrying luxCDABE was subcloned into plasmid
pGRG25 [125] to yield plasmid pBEN275. The promoter for housekeeping gene frr [126]
was amplified from the E. coli K-12 MG1655 genome with primers PG209
(gtctgactcgaggaattcttcccgtgatggataaataag) and PG210 (catcactcgaggttacgaatccttgaaaacttg)
and cloned into the XhoI site of plasmid pBEN275 to yield plasmid pBEN276.
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Bioluminescence Tagging of Salmonella enterica with Plasmid pBEN276
Chromosome based expression of luciferase was established in eleven S. enterica
serotypes using plasmid pBEN276. S. enterica serotypes were grown to logarithmic
phase (OD600 = 0.6-0.8) in preparation of washing with 15% v/v glycerol solution (4x) to
create electrocompetent cells. Cells were stored at -80°C until transformation.
Transformation of six S. enterica serovars (S. Alachua, S. Heidelberg, S. Kentucky, S.
Mbandaka, S. Newport, and S. Senftenberg) with plasmid pBEN276 were conducted by
electroporation using Gene Pulser II System with parameters 2.5 kV, 25 µF, and 400 Ω.
Five S. enterica serovars (S. Braenderup, S. Enteritidis, S. Montevideo, S.
Schwarzengrund, and S. Typhimurium) were transformed with parameters 1.8 kV, 25 µF,
and 600 Ω. Cells recovered in SOC media at 37°C for 1 h. Following recovery, bacteria
suspension was spread on LB + Amp agar to incubate at 37°C for approximately 16 h to
select for successful transformation. Amp resistant colonies were cloned in LB media
supplemented with arabinose at 30°C for approximately 16 h to initiate the transposition
reaction. Cultures were streaked on LB agar to incubate at 42°C for approximately 16 h
to cure plasmid pBEN276. Colonies were picked and cloned in LB media and LB + Amp
media at 30°C for approximately 16 h. Inhibition of growth by Amp confirmed loss of
plasmid pBEN276. The presence of the lux operon was detected using IVIS Imaging
System 100 Series integrated with Living Image Software v2.50.
Characterizing Bioluminescence Properties of Chromosome-Based Luciferase
Expression
Bioluminescent S. enterica serotypes were grown to stationary phase in LB media
and confirmed with bacterial density values (OD600) using Thermomax spectrometer.
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Serotypes were arranged as quadruplicate samples in black clear-bottom 96-well
microtiter plate. A dilution series was prepared for each sample. For each dilution series,
the first four columns consisted of 10-fold dilutions (1 x 100 to 1 x 10-3), and the
remaining eight wells consisted of doubling dilutions (5.00 x 10-4, 2.50 x 10-4, 1.25 x 104

, 6.25 x 10-4, 3.13 x 10-5, 1.56 x 10-5, 7.81 x 10-6, 3.91 x 10-6, 1.95 x10-6, 9.77 x 10-7, 4.88

x 10-7, 2.44 x 10-7). Bioluminescence was measured with IVIS Imaging System 100
Series with 10 s exposure at 37°C and quantified using Living Image Software v2.60.
Bioluminescence was normalized by dividing total flux by OD600 readings. Minimum
detectable bacterial densities were determined from the last two dilutions using plate
counts on LB agar.
Linear correlation formulas were calculated for each serotype using
bioluminescence values and bacterial population numbers determined by duplicate plate
counts. The minimum detectible number for each serotype was identified using the
number of bacteria present in the last dilution that displayed detectable bioluminescence
above background. Colony counts aided in calculation of the theoretical amount of
bioluminescence produced per colony forming-unit (CFU) for each serotype.
Chromosome Stability of lux Operon in Salmonella enterica
Transgene stability was assessed in the chromosome of eleven S. enterica
serotypes by subculturing in LB media approximately every 24 h for a period of 14 d. For
each passage, each culture was inoculated at a 10-fold dilution into fresh 0.3mL cultures
of LB media in black clear-bottom 96-well microtiter plate in quadruplicate. Bacterial
density (OD600) and bioluminescence was determined after approximately 12 h of growth
every 3 d. Bioluminescence was measured using IVIS Imaging System with exposure
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time 15 s at 37°C and normalized by dividing total flux with OD600 readings. The average
normalized bioluminescence for each serotype at each passage revealed the ability of
each serotype to maintain the lux operon in the chromosome without selected pressure.
Evaluation of Bioluminescence Expression at Varying Temperatures
An experimental model was developed to investigate the sensitivity of our
chromosome based luciferase reporter system as an indicator of metabolic activity at
varying temperatures. Bioluminescence expression is a reliable barometer of metabolic
activity due to its requirement of FMNH2 for the luciferase reaction to occur. All
bioluminescence and bacterial density measurements were conducted using LMax
Luminometer (Molecular Devices) with 1 s exposure and SpectramaxPlus 384
spectrophotometer (Molecular Devices), respectively. Cultures of bioluminescent S.
enterica serotypes were grown to stationary phase, approximately 16 h of incubation at
37°C. Cultures were diluted 10-fold with fresh LB media and 0.2 mL of the bacteria
suspension was transferred to black clear-bottom 96-well microtiter plate to incubate at
37°C. Next, the samples remained at 25°C for 10 m and bioluminescence and bacterial
density readings were taken at the conclusion of this time period. Finally, the plate was
refrigerated at 4°C for 2 h, with periodic interruption every 30 m to measure
bioluminescence and bacterial density.
Chicken Skin Assay for Real-Time Monitoring of Bioluminescent Salmonella
enterica
Cultures of bioluminescent S. enterica serovars Mbandaka and Montevideo were
prepared in quadruplicate for this assay. Each culture were grown to stationary phase and
then diluted to approximately 1 x 106 CFU/mL in sterilized distilled water. One mL of
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bacteria suspension was added to 8 mm circular chicken skin sections in black clearbottom 24-well tissue plate as outlined for the skin attachment model. Each sample plate
incubated at room temperature (25°C) for 1 h to allow bacteria to attach to skin.
Following incubation, the excess bacterial suspension was vacuum removed and each
well gently washed with sterilized distilled water. This process was repeated twice to
extract unattached bacteria.
S. Mbandaka and S. Montevideo were subjects for our chicken skin wash assay
with the addition of temperature as a treatment. The treatment group received chilled
water (4°C) and the control group received untreated water, or ambient temperature water
(25°C). After removal of excess bacteria suspension, initial bioluminescence from
bacteria attached to skin sections was quantified using IVIS imaging system with
exposure time 15 s. One mL of 4°C sterilized distilled water was added to each
experimental well for each serotype. The control group for each serotype received one
mL of 25°C sterilized distilled water. Treatment samples were refrigerated at 4°C for a
time period of approximately 2 h on a rotating stage at 200 rpm. The control plate
remained at 25°C for a time period of approximately 2 h on a rotating stage at 200 rpm.
At the conclusion of washing, water containing removed bacteria was vacuumed from
each well to remove unattached bacteria and the samples were warmed to 37°C for 5 m.
Bacteria attached to the skin was quantified by measuring bioluminescence from the
chicken skin samples using IVIS Imaging System. Bioluminescence for each well was
normalized by dividing the total flux of each well by the corresponding bacterial density
value of the original bacterial suspension.
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The difference between the initial total flux of the samples before treatment (0 m)
from the final total flux after treatment (120 m) was calculated to determine the effect
cold washes had on microbial removal from the surface of chicken skin. The difference
value was averaged among the quadruplicates to produce a mean difference value for
each serotype. The mean difference for a serotype of the chilled wash group was
compared to its counterpoint in the wash group by ANOVA using PROC GLM SAS 9.1
to evaluate the effectiveness of chilled wash to remove S. enterica from poultry skin.
Variables in this model included replicate, treatment, and their interaction. Pairwise
comparison of the means was also conducted using Tukey procedure. A significance
level of P ≤ 0.05 was applied in all statistical analyses.
Results and Discussion
Construction of Plasmid pBEN276
Plasmid pGRG25 features a site-specific recombination system based on the
bacterial transposon Tn7 [125]. The Tn7 system inserts at the attTn7 site and is oriented
specifically such that the right end of Tn7 is adjacent to the 3’ end of glmS gene [127],
and it has been used for transgene insertion into the chromosome of Escherichia coli,
Salmonella and Shigella [125]. Plasmid pGRG25 is a temperature-sensitive delivery
plasmid that can be cured after transgene insertion at the attTn7 site by culturing at 42°C.
Plasmid pBEN276 contains the luxCDABE operon between the Tn7 transposon arms on
plasmid pGRG25, and its expression is driven by the E. coli frr promoter (Figure 4.1),
which controls expression of a house-keeping gene encoding ribosome recycling factor.
Thus the lux operon will be expressed constitutively. The chromosomal insertion point is
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specific and insertion of lux operon does not disrupt the function of glmS gene, therefore
it is highly unlikely that bacterial physiology will be affected adversely [125].

Figure 4.1

Plasmid pBEN276 vector

Genes TnsABCD encode the polypeptides required for transposition. The luciferase
genes are encoded in the lux operon which is flanked by the Tn7 transposon arms
(vertical bars at restriction sites XhoI and NotI). The expression of lux genes is driven by
E. coli frr gene promoter which is located between the XhoI sites.
Characterizing Bioluminescence Properties of Chromosomal Luciferase Expression
Plasmid pBEN276 was utilized to insert the bacterial lux operon into the
chromosomes of eleven S. enterica serotypes. Results indicated bioluminescence
correlated well to bacterial population in all serotypes used, as exemplified in S.
Montevideo (P < 0.0001, R2 = 0.994) (Figure 4.2). The minimum detectable
concentration of all eleven serotypes was, in decreasing order (CFU/mL): S. Kentucky –
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8.00 x 104; S. Mbandaka – 4.99 x 104; S. Enteritidis – 3.10 x 104; S. Schwarzengrund –
2.78 x 104; S. Montevideo – 1.74 x 104; S. Alachua – 1.07 x 104; S. Typhimurium – 6.72
x 103; S. Senftenberg – 6.40 x 103; S. Heidelberg – 5.28 x 103; S. Newport – 4.64 x 103; S.
Braenderup– 4.16 x 103. Minimum detectable numbers of S. enterica expressing
bioluminescence from the chromosome were higher compared to minimum detectable
numbers of S. enterica expressing plasmid-based bioluminescence [128]. One possible
explanation for this difference is a copy number effect where a single copy of the lux
operon is inserted into the chromosome with the Tn7 system and only physiological
levels of the luciferase protein will be expressed. In contrast, multiple copies of the gene
are expressed in plasmid systems. For example, plasmid pAKlux1 is a pBBR1 derived
plasmid which characteristically has a medium copy number (~30 copies/cell) [129].
Another possible explanation is due to promoter effect whereas the frr promoter drives
expression of luxCDABE in the Tn7 system, and the lacZ promoter drives expression in
the pAKlux1 plasmid system [128]. Our previous work with plasmid pAKlux1 showed
that bioluminescent S. enterica carrying plasmid pAKlux1 emit, on average, 6.3351
p/s/cm2/sr per CFU [128]; in comparison, S. enterica carrying the lux operon in the
chromosome emit, on average, 0.0795 p/s/cm2/sr per CFU. The intended purpose for this
system is to use it as a screening tool for potential pathogen mitigation strategies, and this
threshold of detection is sufficient for this purpose.
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Figure 4.2

Correlation of bioluminescence against bacterial numbers

The correlation between bioluminescence signal and bacteria numbers for representative
serovar S. Montevideo.

Two different sets of parameters were used to successfully transform all eleven S.
enterica serotypes. These discrepancies may possibly be due to increased activity of
restriction endonucleases in certain serotypes. The lysozyme lysis method for screening
restriction endonucleases has been used to show there is increased restriction nuclease
activity in some Salmonella serotypes [130]. Plasmid pGRG25 is a low copy plasmid and
the large size of the plasmid (14-kb) plus the lux operon (7.1-kb) may make it vulnerable
to restriction endonucleases. Limited compatibility between the bacteria and plasmid may
be an issue and cause the range of application for this reporter system to be limited.
Chromosome Stability of lux Operon in Salmonella enterica
Our group evaluated the stability of the lux operon in the chromosome following
transposition by subcloning bioluminescent S. enterica serotypes under non-selective
conditions for 14 d at 37°C. Previous work from our group with plasmid-based
bioluminescence expression showed the plasmid was unstable without antibiotic selection
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[110, 128]. The average half-life of plasmid pAKlux1, which contains the luxCDABE
cassette, was approximately 7 d in S. enterica serotypes without antibiotic selection. This
current study provides evidence for a 14 d period indicating stability of the lux operon in
the chromosome of these eleven S. enterica serotypes with minimal bioluminescence flux
(Figure 4.3). A notable observation was low initial expression of bioluminescence from
S. Schwarzengrund (105 p/s/cm2/sr). This serotype increased bioluminescence expression
over the course of the experiment and reached similar levels to the other serotypes at
approximately day 10 (107 p/s/cm2/sr). The difference observed for S. Schwarzengrund is
interesting. It is important to note that the Tn7 transposon system does not insert
randomly in the Salmonella chromosome, but insertion occurs only at the attTn7 site [41,
42]. Therefore, ‘luxCDABE mutants’ occurring from undesirable insertions are not
possible. Bacterial density values (OD600) for S. Schwarzengrund were also similar to
bacterial density values for the other serotypes. The contrast in bioluminescence
expression may be attributed to a possible difference in host serotype background.
Determination of the cause of this serotype-specific effect is beyond the scope of the
current research. It is of interest that expression of bioluminescence in S.
Schwarzengrund was also lowest in the plasmid lux system, pAKlux1, reported
previously [128]. These results indicate plasmid pBEN276 can be utilized to construct a
stable reporting system within the chromosome of S. enterica serotypes for use in
extended in-vitro and in-vivo trials.

53

Figure 4.3

Stability of transgene in Salmonella enterica serotypes

S. enterica serotypes carrying transgene luxCDABE in their chromosome were subcloned
under non-selective conditions for 14 d. At every third passage, bioluminescence was
measured and normalized for cell density (OD600).
Evaluation of Bioluminescence Expression at Varying Temperatures
luxCDABE encodes bacterial luciferase which catalyzes the oxidation of reduced
flavin mononucleotide (FMNH2) and a long chain aliphatic aldehyde in the presence of
O2 to produce flavin mononucleotide (FMN) and acid with light emission. Because
FMNH2 production is dependent on a functional electron transport chain, only
metabolically active bacteria emit light [131]. Thus, bioluminescence imaging (BLI)
provides a sensitive real-time measurement of the effects of various chemical, biological
and physical stimuli on bacterial metabolism [132]. We utilized our bioluminescent S.
enterica serotypes to validate our model under a temperature range similar to that which
bacteria in food products are commonly exposed (host to ambient to refrigeration).
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Therefore we investigated the relationship between cellular metabolic activity,
characterized by bacterial light production, and temperature variation. The temperatures
selected were 37°C, 25°C, and 4°C.
Mesophiles, such as Salmonella, grow best in moderate temperatures (15-40°C)
with normal enzymatic activity. In this experiment luciferase reaction within S. enterica
was monitored. At 37°C and 25°C bioluminescence measurements were consistent within
the replicates of the different serotypes. However, a change in temperature will have an
impact on enzyme kinetics. Decreasing temperature, to 4°C, will slow molecular motion
and inhibit the luciferase reaction. Decreasing temperature will also decrease the rate of
metabolism, which translates to decreased concentration of substrate, FMNH2, available
for the luciferase reaction. At 4°C we observed an expected reduction in bioluminescence
signal compared to readings at the two higher temperatures, 37°C and 25°C (data not
shown). However, over the time required (approximately 1 min) to complete
bioluminescence measurements at 25°C a rapid increase in the bioluminescence signal
was observed between the first and the last wells read. Data showed that luciferase
activity is restored shortly after removal from refrigeration temperature. Therefore, the
temperature effect is minimalized after introduction to ambient temperatures (≥25°C).
These results validate that our bioluminescence reporting system can monitor bacteria
within a temperature range that food products are commonly exposed.
The stage on our luminometer has adjustable temperature with the lowest
temperature setting being 25°C. Future work will include a refrigerated state for the
reading stage to eliminate temperature variation.
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Chicken Skin Assay for Real-Time Monitoring of Bioluminescent Salmonella
enterica
Salmonella represents a major issue for the poultry industry, and due to its
persistence during the processing of chicken carcasses, the pathogen is difficult to
eliminate the bacteria from chicken carcasses without proper cooking. The physiological
mechanisms enabling the bacteria to persist throughout the processing continuum are not
fully understood. Food safety necessitates attention to be focused on the comprehension
of the mechanics of attachment of the bacteria in order to limit Salmonella as a food
safety concern.
We have developed a chromosome based luciferase experimental model capable
of real-time monitoring of bacteria viability and evaluating pathogenic mitigation
strategies. Furthermore, the potential of this model may be of practical use in shedding
light on how Salmonella is able to persist during the processing continuum. To
demonstrate the potential value of this model as a screening tool, the performance of our
bioluminescent S. enterica serotypes on chicken skin sections at two temperatures in an
aqueous environment was evaluated. Serovars S. Mbandaka and S. Montevideo were
selected for this skin attachment experiment based on the consistent bioluminescence
expression observed within these serotypes (Figure 4.3). Individual aqueous solutions,
each containing a S. enterica serotype, were prepared and introduced to chicken skin
samples according to the skin attachment protocol (described previously). Separate black
clear-bottom 24-well tissue plates, containing replicates of each serotype, were placed on
a rotating stage at 4°C and 24°C for 2 h. Following this period, bioluminescence imaging
was collected after a 5 m interval at 37°C for both serotypes, indicating bacteria numbers
on chicken skin following cold and warm washes (Figure 4.4). Our previous work
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demonstrated washing with 25°C water suppressed the reproduction of Salmonella on
chicken skin likely through the physical removal of bacteria [128]. Given that Salmonella
is a mesophile, refrigeration temperatures further limit bacterial growth and the bacteria
become metabolically static. Bioluminescence values at post-wash (4°C) were not shown
to be significantly different compared to pre-wash values for both serotypes (P ≥ 0.25).
Bioluminescence values at post-wash (25°C) were greater compared to pre-wash values
but the difference was not shown to be significantly different (P ≥ 0.125). The increase in
bioluminescence following the 25°C wash period is due to increased bacteria growth
under favorable metabolic conditions (temperature) and nutrients provided by the chicken
skin in solution. Our chromosome based luciferase model was able to quantify a change
in bacteria number by monitoring bioluminescence following treatment.
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Figure 4.4

Comparison of the amount of Salmonella before and after 2 h incubation

The change in bioluminescence on chicken skin following 2 h incubation for 25°C and
4°C water washes. A) S. Mbandaka. B) S. Montevideo.
Results from our model provide the framework for further studies to evaluate the
efficacy of pathogen mitigation strategies, i.e. antimicrobial compounds and processing
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parameters that may be applied in poultry processing to control Salmonella. Future work
with our chromosome based luciferase reporter system in our chicken skin model will
feature an extended time course to better reflect the duration of exposure to conditions
bacteria might be subjected to in the poultry processing environment.

Summary
In this chapter, a novel, real-time reporting system was successfully introduced
into Salmonella enterica serotypes. The luxCDABE operon was transposed from plasmid
pBEN276 to the insertion site attTn7 in the bacteria chromosome. The transposed gene
was shown to be stable without external selection. This reporting system was shown to
respond quickly following decreased metabolic activity due to refrigeration. Additional
results with our chicken skin attachment model provide support for application of our
model in trials simulating processing plant environmental conditions, with specific focus
on immersion chilling. Extended research with our model will look at mechanisms of
interaction of Salmonella with chicken skin using eukaryotic cell monolayers.
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CHAPTER V
DETERMINATION OF MOLECULAR COMPONENTS INVOLVED IN
SALMONELLA INFECTION OF NONPHAGOCYTIC CELLS

This research is focused on the underlying bacteria-cell interactions of the
invasion event initiated by Salmonella that occurs at the site of the epithelium lining of
the gastrointestinal tract of its host. A standard gentamicin protection assay was
conducted to study invasion in an adenocarcinoma colon epithelial cell line by S. enterica
serovars Kentucky and Typhimurium. Deletion mutation strains were created for each
serotype with λ Red recombination and PCR products to disrupt type III secretion system
(T3SS) expression. Three comparison studies were conducted on the invasion results
between strain and corresponding mutant, between serotypes, and between corresponding
serotype mutant strains.
Methodology
Bacterial Strains and Plasmids
S. enterica serovars Kentucky and Typhimurium (hereafter referred to as
Kentucky and Typhimurium, respectively) were isolated from the field as part of
previous work to isolate and catalogue Salmonella specimens from the poultry processing
continuum [109]. Plasmids pKD46, pKD3, and pCP20 were purchased from Coli Genetic
Stock Center at Yale University (Hartford, CT).
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Preparation of Competent Cells and Electroporation
In order to prepare competent cells, a colony of Salmonella was inoculated in 5
mL LB media and incubated at 37°C with agitation at 200 rpm for approximately 16-20
h. The following day, 2 mL of the culture were transferred to freshly prepared 100 mL
LB media and incubated at 37°C with agitation at 200 rpm. If appropriate, 10 mM Larabinose was added to culture to prepare λ Red recombinase. Following 1 h incubation,
OD600 was observed every hour while in lag phase and every 15-20 m once in log phase.
Once OD600 reached 0.6-0.8, the culture was placed on ice for approximately 15 m to
suspend growth. The culture was aliquoted equally into four 50 mL centrifuge bottles and
kept on ice until ready to centrifuge. Each tube was centrifuged at 10,000 rpm for 10 m at
4°C. The supernatant was immediately poured off and 25 mL cold sterilized glycerol
water (15% glycerol) was added to each bottle to resuspend the bacteria. The centrifuge
process was repeated with fresh glycerol water. After the third spin, the supernatant was
poured off and the bacteria pellets from the four tubes were combined into one tube with
25 mL glycerol water. The tube was centrifuged once more and the supernatant poured
off and bacteria resuspended in the remaining liquid. Preparation of cells for
electroporation was complete.
Standard electroporation was followed as 100 μL competent cells were combined
with 2 μL DNA in 1.5 mL microcentrifuge tube. Solution was transferred to 1 mm gap
cuvette and pulsed at 1.8 kV. Cells recovered in 500 μL S.O.C. media at 30°C for 1-5 h.
Cultures were spread on LB agar with appropriate antibiotic and incubated at 30°C with
agitation at 200 rpm for approximately 24 h.
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Construction of SPI Deletion Mutations
A series of deletion mutations were created within Salmonella Pathogenicity
Island-1 (SPI1) in Kentucky and Typhimurium following a method developed by
Datsenko and Wanner to delete structural genes critical to the proper function of T3SS
[133]. This method has been successfully applied to inactivate genes within E. coli and S.
enterica serovars Typhimurium and Enteritidis [12, 134, 135]. Briefly, phage λ Red
recombinase, encoded on plasmid pKD46 replaced a chromosomal sequence with a PCR
fragment that has homologous regions adjacent to the chromosomal sequence (Figure
5.1). The 40-nt homologous regions were designed from S. enterica Kentucky genome
shotgun sequence (GenBank accession no. ABAK02000001.1) and S. enterica
Typhimurium str. SL1344 (NCBI Reference Sequence: NC_016810.1). The 1.1-Kbp
PCR fragment was generated using the 40-nt homologous extensions as primers (Table
5.1) from template pKD3 (Figure 5.2).
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Figure 5.1

Gene disruption strategy using PCR products

To create the deletion mutation within our strain, (step 1) an antibiotic resistance gene
was PCR amplified with primers which had 40-bp tails that were homologous to the
flanking regions adjacent to the gene of interest. (step 2) λ Red recombination replaces
the chromosomal sequence with the antibiotic resistance markers. (step 3) The antibioticresistant transformants were selected. (step 4) The resistance gene was removed by a
helper plasmid. H1 and H2 refer to the homology regions. P1 and P2 refer to priming
sites.
Table 5.1

Primer sequences

Primer

Sequence

Length

CVM29188.01F

TCATTTAATTGCCTCCTGACCTCTATCCAGATAAACACGAgtgtaggct
ggagctgcttc

60

CVM29188.02F

TTATATTGTTTTTATAACATTCACTGACTTGCTATCTGCTgtgtaggctg
gagctgcttc

60

CVM29188.03F

TCAATGCCGTACCTCGTTTTCTTGTGGCTGAATAACGTCTgtgtaggct
ggagctgcttc

60

CVM29188.01R

GCGGAAATTATCAAATATTATTCAATTGGCAGACAAATGAcatatgaa
tatcctccttag

60

The CVM29188.01F, CVM29188.02F, and CVM29188.03F primers harbor 40
nucleotides (in uppercase) that bind upstream of the invG gene, invA gene, and spaS
gene, respectively, and 20 nucleotides (in lowercase) that correspond to P1.
CVM29188.01R harbors 40 nucleotides (in uppercase) that bind downstream of invG
gene, and 20 nucleotides (in lowercase) that correspond to P2.
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Figure 5.2

Template plasmid pKD3

(A) Arrowheads indicate location and orientation of priming sites. P1: priming site 1; P2:
priming site 2. c1, c2, and ct: common test primers. FRT (FLP recognition target) sites
flank chloramphenicol acetyl transferase gene at (51-84) and (981-1,022). Numerals
identify nucleotide location in template plasmid pKD3 sequence (GenBank accession no.
AY048742.1). (B) Linear representation of template plasmid pKD3.
The amplified PCR fragment from plasmid pKD3 encodes chloramphenicol
acetyl transferase (CAT). Plasmid pKD46 transformants containing the PCR fragment
after electroporation were selected for successful recombination events within the
chromosome using chloramphenicol (Cm) antibiotic pressure, (10 μg/mL). Following
selection, the resistance gene was eliminated using helper plasmid pCP20, which targets
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specific FRT (FLP recognition target) sites flanking the resistance gene for
recombination [136]. Three deletion mutation events were scheduled for structural genes:
invG, invAEG, and spaSRQPO-invJICBAEG.
Growth Kinetics
Growth analysis was conducted for wild-type Kentucky and Typhimurium and
their corresponding strains with mutation ΔspaSRQPO-invJICBAEG to determine if
bacteria replication was affected by the mutation. Separate cultures were prepared by
inoculating fresh LB media with one colony of each serotype and strain and incubated for
approximately 16 h at 37°C with agitation at 200 rpm. Following incubation, OD600
values for each culture were adjusted to 1.000 in fresh LB media. Triple technical
replicates were prepared for each sample by diluting the culture 1/1000 in fresh LB media
and incubated at 37°C with agitation at 200 rpm. At scheduled time points, starting at 0 h
and occurring every hour to 14 h, OD600 was observed for each sample. The average
OD600 values were determined from triple technical replicates for each serotype and
strain. The averages were plotted against time (m) to create a growth curve depicting
bacteria replication as a function of time.
Further growth analysis was conducted to establish viable bacteria number
estimates in relation to OD600 values. Separate cultures were prepared by inoculating
fresh LB media with one colony of each serotype and strain and incubated for
approximately 16 h at 37°C with agitation at 200 rpm. Following incubation, OD600
values for each culture were adjusted to 1.000 in fresh LB media. Quadruple technical
replicates were prepared for each sample by diluting the culture 1/1000 in fresh LB media
and incubated at 37°C with agitation at 200 rpm. At time point 0 h, an aliquot from each
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culture was obtained and diluted 10-3 in 0.01 M phosphate buffered saline (PBS) (SigmaAldrich, St. Louis, MO) and 25 μL aliquots were spread on LB agar to enumerate colony
forming unites (CFU). Following 6 h period, an aliquot from each sample was removed,
diluted 10-5 and 10-6 in 0.01 M PBS and 25 μL aliquots were spread on LB agar to
enumerate CFU. The previous step was repeated for a successive 6 h period and data
collected as previously outlined. Data from the quadruple technical replicates at each
time point was gathered to generate a XY scatter plot for each serotype and strain to
predict bacteria number in relation to OD600. The data was statistically analyzed using
linear regression model (PROC REG) SAS for Windows v9.3. All statistical comparisons
were two-sided using P ≤ 0.05 as the significance level.
Cell Culture
Human colorectal adenocarcinoma epithelial Caco-2 cells (ATCC HTB-37;
ATCC, Manassas, VA) were grown in Eagle’s Minimum Essential Medium (EMEM)
(ATCC, Manassas, VA), supplemented with 20% fetal bovine serum (FBS) (Access,
Vista, CA) and 2 mM L-glutamine (EMEM-FBS), and maintained at 37°C in 5% CO2
and 95% air, in 75 cm2 flasks, unless stated otherwise. Trypsin-treated cells were seeded
into 12-well tissue culture plates (Becton and Dickinson and Company, Franklin Lakes,
NJ) at approximately 1 x 104 cells per well and grown at 37°C and 5% CO2/95% air.
Cells averaged 2-4 d to reach 95-100% confluent monolayers (approximately 5 x 105
cells/well). Cell media was exchanged every 2-3 d. Cell number was determined by
hemocytometer counts.
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Bacterial Infection of Caco-2 Cell Monolayers
To determine rate of invasion of Caco-2 cells by Kentucky, Typhimurium, and
their corresponding mutant strains, a gentamicin protection assay was performed as
described previously [137, 138], with modifications. Briefly, fresh LB media was
inoculated with one colony (Kentucky, Kentucky [ΔspaSRQPO-invJICBAEG],
Typhimurium, Typhimurium [ΔspaSRQPO-invJICBAEG]) and incubated for
approximately 16 h at 37°C with agitation at 200 rpm. Cultures were adjusted to OD600 =
0.800 and then diluted 1/1000 in pre-warmed complete cell media to achieve a
predetermined bacteria number and transferred to Caco-2 monolayer cells at multiplicity
of infection (MOI) 1:1. Tissue culture plates were briefly centrifuged at 400 rpm for
approximately 1 m to bring bacteria into close proximity with the cell monolayer prior
incubation for 1 h at 37°C. Removal of cell media with bacteria preceded 2x washes with
0.01 M PBS. Pre-warmed cell media supplemented with gentamicin (200 µg/mL; Gibco)
was added to eliminate extracellular bacteria while plates incubated for 1 h at 37°C. Cell
media solution was removed and saved to be spread (100 μL) on nonselective agar to
confirm antibiotic action. Monolayers were washed twice with 0.01 M PBS, then 500 µL
cold Triton X-100 (0.1% v/v 0.01 M PBS) was added to lyse cells. Cell suspension was
collected, diluted 10-1 or 10-2, and spread onto nonselective agar in 100 µL aliquots.
Viable bacteria were enumerated and adjusted to estimate CFU/mL. Each strain consisted
of eight replicates for each trial and the assay was repeated for three separate trials. The
data was statistically analyzed using mixed linear model (PROC MIXED) SAS for
Windows v9.3. Strain was the fixed effect and random effects were trial and trial(strain).
The least square means were used to determine statistically significant differences
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between strains with respect to the mean CFU/mL. All statistical comparisons were twosided using P ≤ 0.05 as the significance level.
Annotation
For annotation, the whole genome shotgun sequence of S. enterica Kentucky str.
CVM29188 (GenBank accession no. ABAK02000001.1) and whole genome sequence of
S. enterica Typhimurium str. SL1344 (NCBI Reference Sequence: NC_016810.1) were
uploaded to the RAST (Rapid Annotation using Subsystem Technology [ref]) server in
FASTA format. The genomes were compared on function-base using RAST
(http://rast.nmpdr.org/) to identify serotype-specific protein-encoding, rRNA, and tRNA
genes and assign function to the genes.
Results And Discussion
Construction of SPI Deletion Mutations
Three sites within SPI1 were targeted for deletion to disrupt T3SS function in
Kentucky and Typhimurium. PCR products were generated from pairs of 60-nt primers
that included 40-nt homology extensions and 20-nt priming sequences complementary to
plasmid pKD3 as template (Table 5.2). The PCR products were purified and then
transformed into bacteria carrying the λ Red helper plasmid as described previously to
create three separate deletion events within the structural genes of T3SS. The mutations
were precisely targeted for invG, invAEG, and spaSRQPO-invJICBAEG (Figure 5.3).
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Table 5.2

Gene disruptions using λ red recombinase

Mutation

Homology Extensions

Priming Sites

ΔSPI1(invG)1705

40 nt; Ha: 2345733; H2: 2347418

P1; P2

ΔSPI1(invA-invG)4902

40 nt; Hb: 2342536; H2: 2347418

P1; P2

ΔSPI1(spaS-invG)11769

40 nt; Hc: 2335669; H2: 2347418

P1; P2

All disruptions were made in pKD46 transformants of BW25113. Extension lengths are
given first. Numerals identify the 3’ nucleotide of the extension in the Kentucky genome
shotgun sequence (GenBank accession no. ABAK02000001.1). One primer had the Hχ
(a, b, or c) extension and the 3’ sequence for priming site 1 (P1). The other primer had
the H2 extension and the 3’ sequence for the complement of priming site 2 (P2). Priming
sites P1 and P2 associated with plasmid pKD3 [133].
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Figure 5.3

Structures of type III secretion system mutations

Top line shows Salmonella Pathogenicity Island-1. (A-C) Structures of the mutations
generated using plasmid pKD3 as template. Numerals above the structures refer to locusspecific primers. The predicted PCR products are shown. C, complement; Hχ, homology
χ (a, b, c, or 2).
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Figure 5.4

Type III secretion system basal structure

The basal structure spans the outer membrane, peptidoglycan layer, and the inner
membrane. The outer membrane ring is formed by invG. The export apparatus is
associated with the inner membrane and consists of invA, spaS, spaR, spaQ, and spaP.
Mutations of this nature interrupt the proper formation of the basal structure that
anchors the needle to the bacterial membranes and disrupts T3SS function (Figure 5.4).
The outer membrane ring of the basal structure is formed by the integral membrane
protein invG [139]. The export apparatus complex serves as a platform for the assembly
of the basal structure and is composed of highly conserved integral membrane proteins:
spaS, spaR, spaQ, spaP, and invA [140]. Protein spaS has additional function to regulate
secretion specificity of the virulence effectors through the base [141].
Cm resistance (10 μg/mL) phenotype indicated successful mutations. Antibiotic
resistance gene was eliminated by FLP recombinase, expressed from helper plasmid
pCP20, which targets the repeated FRT (FLP recognition target) sites flanking the
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resistance gene. Elimination of the antibiotic resistance gene leaves an 85-nt scar (Figure
5.5) in place of the deleted gene(s) that has stop codons in all six reading frames [133],
thereby creating nonpolar gene deletions. Downstream gene expression can continue due
to a ribosome binding site and start codon that is encoded in the scar sequence [133].

Figure 5.5

Sequence after FLP-mediated excision

Predicated ‘scar’ sequence remaining after FLP-mediated excision of the
chloramphenicol resistance gene. Arrows with open arrowheads show the FRT site
inverted repeats. The ribosome binding site (rbs) and methionine (met) start codon are
marked.
All gene deletion mutations were verified by PCR tests using locus-specific
primers and CAT-specific primers revealing that all strains had new junction and locusspecific fragments of the predicted sizes (Figure 5.6). Following elimination of the
resistance gene, PCR test with locus-specific primers indicated the deletion mutants
produced the expected junction fragments and verified mutations occurred in the
designed location.
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Figure 5.6

Sequence of type III secretion system mutation junctions
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Figure 5.6 (Continued)
Chromatograms of the newly formed DNA sequences from Kentucky following
recombination. A) The 5’ sequence of the ΔSPI1(invG)1705 mutation. B) The 5’
sequence of the ΔSPI1(invA-invG)4902 mutation. C) The 5’ sequence of the ΔSPI1(spaSinvG)11769 mutation. D) The 3’ sequence of the three mutations.
Growth Kinetics
Growth analysis was conducted for Kentucky, Typhimurium, and the
corresponding mutation strains to determine if bacteria replication was affected by the
deletion mutation. Bacterial cultures were adjusted to equal concentration, diluted 1/1000
in media and OD600 values were determined from 3 h to 14 h at every hour during
incubation at 37°C at 200 rpm. The OD600 values were averaged from triple technical
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replicates and plotted as a function of time (m) for each serotype and strain (Figure 5.7).
Deletion mutations created within SPI1 were not observed as affecting bacterial
replication by Kentucky or Typhimurium in relation to their corresponding wild-type
strains.

Figure 5.7

Bacterial concentrations as a function of time

Average of triple technical replicates for A) Kentucky, B) Typhimurium, and
corresponding deletion mutant strain (ΔspaS-invG) plotted as OD600 values on the y-axis
as a function of time (m) on the x-axis.
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Further growth analysis was conducted to confirm viable bacteria number relative
to OD600 values for each serotype and strain. At time point 0 h, cultures were diluted 10-3
in 0.01 M PBS, and at time points 6 h and 12 h, cultures were diluted 10-5 and 10-6 in 0.01
M PBS and 25 μL were spread on LB agar. Colony forming units were counted and
adjusted to CFU/mL from four technical replicates for each serotype and strain at 0 h, 6
h, and 12 h. For all serotypes and strains, the model used for linear regression analysis
indicated a significant portion of the variation in CFU/mL was due to OD600. The
statistical analysis, including regression equation, R-squared value, P-value, for each for
each serotype and strain follows (Figure 5.8).
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Figure 5.8

Fit Plot for Colony Forming Units (CFU) / mL
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Figure 5.8 (Continued)
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Figure 5.8 (Continued)
At each time point, cultures were diluted either 10-3 or 10-5 and 10-6 in 0.01 M PBS and
25 μL of bacteria suspension were spread on LB agar. Colony forming units (CFU) from
each dilution were enumerated and adjusted to CFU/mL. CFU/mL along the y-axis was
plotted as a function of OD600 on the x-axis in XY scatter plot to predict CFU relative to
OD600. The regression equations, R-squared value, and P-value were determined for each
serotype and strain.
Bacterial Infection of Caco-2 Cell Monolayers
A standard gentamicin protection assay was modified for this study to determine
the capacity of each strain to infect a monolayer of human colorectal adenocarcinoma cell
line Caco-2. Following 1 h invasion time, extracellular bacteria were eliminated by
supplementation of new cell media with gentamicin. Following subsequent 1 h incubation
period, the cell media with gentamicin was removed and 100 μL was spread on
nonselective media (LB, MacConkey, or Brilliant Green agar) to confirm the elimination
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of extracellular bacteria. The absence of CFU verified that gentamicin at concentration
200 μg/mL for 1 h was sufficient to eliminate extracellular bacteria (data not shown).
Caco-2 cells were lysed with cold 0.1% v/v Triton X-100 diluted in 0.01 M PBS and the
cell suspension collected. Wild-type Typhimurium was diluted 10-1 in 0.1 M PBS, the
remaining three cell suspensions were not diluted, and 100 μL of the suspensions were
spread on nonselective media. Viable bacteria numbers as a result of invasion were
determined from plate counts and adjusted to estimate bacteria number per mL (Figure
5.9). Statistical significance of invasion rates for each strain was determined with SAS
Windows v9.3 using mixed linear model and significance level P ≤ 0.05.
Invasion Rates of Wild-type Kentucky and Typhimurium
As wild-type Typhimurium has adapted to humans as a host, a relatively high rate
of invasion, approximately 185,625 CFU/mL, in comparison to Kentucky was expected
(Figure 5.9). The invasion rate for wild-type Kentucky was significantly less in
comparison to wild-type Typhimurium, approximately 3921 CFU/mL. Though Kentucky
is currently the most frequently isolated serotype in commercial poultry, Kentucky is less
commonly associated with human disease. Kentucky was not among the 20 most
frequently reported serotypes listed for the United States in 2011 [142]. Based on a
review of recent scientific literature, to our knowledge, this is the first study to
demonstrate in vitro invasion of a human cell line by Kentucky.

80

Figure 5.9

Estimated rate of invasion of Caco-2 cell monolayer by wild-type strains

Wild-type strains are expressed along the x-axis. Bacteria number are expressed along the
y-axis and estimated per mL for 1 h invasion period. Strains with the same letter are not
statistically different at P ≤ 0.05.
The frequent isolation of Kentucky serotypes in commercial poultry, especially
MDR strains, is significant from a public health standpoint. Angulo et al. suggests that
resistance reservoirs in food animals can possibly promote the spread of resistance
determinants among bacteria and lead to antimicrobial-resistant infections in humans
[143]. Within the last decade, a MDR isolate of Kentucky displaying high-level
resistance to ciprofloxacin was disseminated internationally with poultry suspected as the
potential major vehicle for infection [105]. The strain identified ST198-X1 CIPR infected
nearly 500 patients in France, England and Wales, Denmark, and the United States during
2002-2008 with travel to northern Africa in common [105]. Kentucky isolates have been
reported in Europe from travelers returning from northern Africa [106, 107] and more
recently, Kentucky isolates with similar macrorestriction patterns to the isolates observed
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in Europe and Africa have been reported in Canada [108]. A majority of the S. Kentucky
strains identified were ciprofloxacin-resistant [106-108], and many of the strains
contained Salmonella genomic island 1 variants [108], resulting in treatment failure with
traditional antimicrobials against nontyphoidal Salmonella infections due to high level of
resistance.
Certain genetic factors have been hypothesized to be responsible for the
emergence of Kentucky in poultry. In a comprehensive study of S. enterica serotypes,
Kentucky was shown to have a slight growth advantage over other serotypes in mildly
acidic environments (pH = 5.5), which may be beneficial in the mildly acidic
environment of the cecum [144]. However, studies examining the colonization factors
contributing to the emergence of Kentucky in poultry remain few. This serotype shares
virulence genes with other Salmonella serotypes which are implicated in the colonization
and infection of the gastrointestinal tract, however, mechanisms differ between serotypes,
and even within an individual serotype, underscoring how gene expression can
significantly affect these functions. The discrepancy of Caco-2 cell invasion rate between
Typhimurium and Kentucky is possibly due to discrimination in target host by serotype
related to genetic factors impacting host specificity including those linked with
recognition and adhesion to intestinal surfaces and mechanisms of invasion of epithelial
cells.
The factors initiating colonization for Typhimurium have been studied
extensively for multiple hosts. Recognition and adhesion by Salmonella Typhimurium
str. 798 to enterocytes in mouse and pig were related to phase variant expression of type I
fimbriae [75]. Additional findings focused on Salmonella Typhimurium highlighted the
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important role fimbriae has to facilitate adherence and adaptation to a eukaryotic cell
surface [145]. Genes associated with lipopolysaccharide biosynthesis have been
determined to influence intestinal colonization of 3-week-old chicks by Salmonella
Typhimurium F98 [146]. Less is known about the genes associated with recognition and
adhesion for Kentucky and given the range colonization mechanisms can vary between
hosts and within an individual serotype, the identification of factors influencing host
colonization and adaptation unique to Kentucky would seem practical to comprehending
its recent emergence in poultry.
The recent rise of Kentucky may correspond with its acquisition of a ColV
virulence plasmid [103]. Enhancement of colonization induced by ColV plasmid has been
observed for E. coli in animal models [147, 148] and ColV plasmid has been associate
with conferring virulence factors such as resistance serum [149] and oxidative stress
[150], promotion of iron acquisition [151], and metal transporters [150]. Of 293 isolates
of Kentucky that were examined for the presence of ColV plasmid-associated genes, 213
(72.9%) contained all of the expected genes [152]. In the same study, a comparison
between three sequenced Kentucky ColV plasmids, whose host strains differed in
temporal and spatial isolation and source, revealed the plasmids were essentially
identical. Considering the typical heterogeneous genetic nature of ColV plasmids [153]
and the congruency of the ColV plasmids isolated from the Kentucky strains, a single
horizontal transfer event may have occurred that resulted in clonal expansion of a
prominent clonal type of Kentucky in poultry [152]. The presence of the ColV plasmid is
a compounding factor that may enhance the persistence of Kentucky in the avian host and
suggests that Kentucky has the ability to acquire and disseminate large plasmids encoding
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MDR and virulence [103]. As some plasmids are capable of autonomous restriction and
modification, determinants for host specificity may be integrated into plasmid DNA
molecules and then acquired by the pathogen. Given the prominence of Kentucky in
commercial poultry and poultry products [98-101] and the latest cluster of MDR
Kentucky cases isolated from humans [106-108, 154, 155] associated with ColV plasmidassociated genes [152], a potential opportunity exists for Kentucky to adapt, expand its
host range and become a considerable zoonotic pathogen.
Invasion Rates of Wild-type and Mutation Strains
The deletion mutation (ΔspaS-invG) of the structural genes associated with T3SS
decreased the rate of invasion for both serotypes in comparison to their wild-type strain.
Human cells are typically not the specified host for Kentucky and so the invasion rate for
the wild-type strain is limited (3921 CFU/mL). The loss of T3SS function reduced
invasion 38.1% from the wild-type to 2425 CFU/mL (Figure 5.10) which was not
significant (P ≤ 0.05). Invasion by Typhimurium was significantly affected by the
disruption of T3SS function, decreasing invasion 85.1% from the wild-type to 12445
CFU/mL. This reduction of invasion rate resulted from the inactivation of T3SS function,
which signifies the prominent role this multi-protein complex system contributes to
facilitating invasion, a finding that corresponds with previous scientific findings
concerning the role of T3SS [80, 89, 156, 157]. Active invasion of epithelial cells by the
mutation strains represents possible alternative mechanisms of invasion that may act
independently and/or in a supplemental role to T3SS.
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Figure 5.10

Comparison of rate of invasion of Caco-2 cell monolayer

Strains are denoted along the x-axis. Bacteria number are expressed along the y-axis and
estimated per mL for 1 h invasion period. Strains with the same letter are not significantly
different at P ≤ 0.05.
Our results correspond with previous findings that suggest infection by
Salmonella can occur in a manner independent of T3SS [10, 89, 90, 158]. The Salmonella
species appearing in the aforementioned studies were serotypes with broad host ranges.
To our knowledge, this is the first study to replicate invasion, suggestive of T3SSindependent mechanisms, by a Salmonella serotype in a host not traditionally within its
range. Due to the nature of invasion by Kentucky in the case of human colorectal
epithelial cells, this possible alternative mechanism may exist as a minor invasive
function with an ‘indiscriminative’ host range. Salmonella is capable of infecting diverse
hosts and cells types and is an implication of this research that an ‘indiscriminative’
mechanism may be evolutionarily beneficial to target a broad range of hosts.
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An outer membrane protein has shown promise as an entry mechanism able to
induce cellular invasion independently of T3SS. Rck is a 19-kDA outer membrane
protein encoded on the large virulence plasmid [91] whose expression was necessary and
sufficient to enable non-invasive E. coli and Rck-coated beads to adhere to and invade
epithelial, fibroblastic, and endothelial cells through modulation of actin-mediated
internalization [92]. The role of Rck in Salmonella invasion has been demonstrated in
vitro after growing Salmonella in swarming culture conditions [159], however, its precise
role in Salmonella pathogenesis and its cellular receptor are poorly understood.
Additional factors have been postulated to influence surface cell rearrangements
of enterocytes and affect invasion of eukaryotic cells. Outer membrane protein PagN
interacts with haperain sulfate proteoglycans on the surface of eukaryotic cells and
overexpression of PagN in a noninvasive E. coli strain induced cell invasion [160, 161].
However, replication of PagN activity has occurred under limited environmental
conditions and although PagN mediates interaction between Salmonella and mammalian
cells, its role as an invasin remains uncertain. Reports conflict over the role of type VI
secretion system [162, 163], though deletion of Salmonella Pathogenicity Island-6
resulted in decreased ability of Salmonella Typhimurium to enter cultured HEp-2 tissue
culture cells [162].
The internalization into nonphagocytic cells of the intestinal epithelium is central
to the pathogenesis of Salmonella, especially in relation to the maturation of infection.
Most certainly it is viable to expect multiple mechanisms that perform overlapping
functions to preserve the invasion process. The majority of the invasion factors studied
manipulate host signaling pathways to activate host actin nucleation to mediate the
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uptake of Salmonella into host cells [164, 165]. However, recently Salmonella
Typhimurium was shown to manipulate additional signaling pathways leading to
actomyosin-mediated contractility, suggesting a flexibility to target different cell types
and/or subcellular regions [166, 167].
Summary
In this research, two strains of Salmonella enterica were investigated for their
ability to induce internalization by human colorectal adenocarcinoma epithelial Caco-2
cells. Serovar Typhimurium is well adapted for invasion of human cells. Serovar
Kentucky has been identified in commercial poultry, especially MDR strains, however
this serotype is not typically a zoonotic pathogen. Disparities in the ability of each
serovar to invade Caco-2 cell monolayers were shown. The Type III Secretion System
(T3SS), a known mechanism for active cell invasion, was disrupted through genetic
deletion of structural genes associated with function of the secretion system. The genetic
mutation caused a decrease in the efficiency of invasion in comparison to the control,
though complete cessation of invasion was not seen. Future research from this work
includes a closer examination of the factors associated with serovar and host that affect
host specificity for invasion, as well as, mechanisms that may play a supportive role to
T3SS.
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CHAPTER VI
CONCLUSION

The research presented here is an extensive study on the specie of Gram-negative
bacteria Salmonella and its implication as a major food borne pathogen in the present
food processing continuum. Within this study, a bioluminescent reporting system for
Salmonella was introduced as plasmid pAKlux1. This reporting system is a major step
forward in laboratory detection and tracking of Salmonella. Whereas conventional
culturing techniques followed a time frame of 48 to 72 hours, bioluminescence imaging
provides real-time quantification and tracking of live bacteria within its host.
Additionally, the luciferase reaction does not require any exogenous substrates.
Application of this reporting system with a chicken skin attachment model developed for
this research, yielded results that demonstrated the variation that Salmonella serovars
show in their ability to attach to chicken skin. The ability of a serovar to attach to chicken
skin may correlate with its ability to persist in poultry production. Further work with this
reporting system and attachment model indicated that simple washing in an agitated
water bath can remove contaminating Salmonella from chicken skin, however this
method alone cannot eliminate the Salmonella completely due to strong bacterial
attachment to skin. Therefore, additional methodologies should be used in poultry
processing to eliminate Salmonella from the chicken skin to prevent foodborne disease
outbreaks.
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A limitation of the pAKlux1 reporting system is that stability experiments showed
the plasmid was not as stable in Salmonella as in other Gram-negative species, and this
reporting system may not be useful for long-term experiments. To address this limitation,
plasmid pBEN276 was constructed to transpose the luxCDABE operon into the
chromosome of Salmonella at one specific site. Strains harboring the gene insertion were
rapidly detected following metabolic stagnation due to refrigeration temperatures upon
return to ambient temperature. This result was further confirmed in a chilled water
experiment with our chicken skin attachment model. Our results showed that washing in
chilled water further enhanced the effect the agitated water bath had on decreasing
Salmonella on chicken skin by further suppressing replication due to metabolic
stagnation. Bacteria quantification was done with bioluminescence imaging and
demonstrated that this stable reporting system could be employed in experiments
replicating immersion chiller settings. The immersion chiller tank is a step within
commercial processing of broiler carcasses that has been indicated as the point of most
significant cross-contamination. Further research is needed to investigate the mechanisms
of interaction between Salmonella and chicken skin that lead to initial contamination of
the skin and the factors that enable persistence of the bacteria in the host.
Salmonella enterica serovar Kentucky has close association with poultry and
poultry products and is usually among the most commonly isolated serovars as listed by
U.S. Department of Agriculture (USDA) and Food Service Inspection Service (FSIS).
Traditionally, S. Kentucky is not a zoonotic pathogen though recent reports have shown
cases of S. Kentucky isolated from humans. The factors limiting or enhancing host
specificity remain unclear. In this research, Salmonella enterica serovar Typhimurium, a
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known human pathogen, and S. Kentucky were genetically mutated to disrupt the
function of the Type III Secretion System (T3SS). The T3SS is a unique protein delivery
system that is involved with the induction of internalization of the bacteria by previously
nonphagocytic cells. Using human colorectal adenocarcinoma epithelial Caco-2 cells as
the matrix in a gentamicin protection assay, an experiment was designed to determine the
rate of invasion by the two Salmonella serovars and their corresponding mutant strains.
Results showed that S. Kentucky was able to actively invade the eukaryotic monolayer,
though at a rate that was significantly lower than S. Typhimurium. Additionally, the
mutated strains were able to initiate invasion of the eukaryotic monolayer, though not as
effectively as the wild-type strains. Serovar discrepancies for invasion were seen with the
mutated strains as well. The results from the invasion assay provided the basis for
additional research to the factors delineating host specificity. These factors may act as
potential targets as vaccination candidates. Extended research may also be aimed at the
mechanisms of invasion that supplement the role the T3SS plays in host invasion.
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CHAPTER VII
FUTURE RESEARCH

The body of work accumulated for my dissertation has provided a strong basis
upon which future research may stem from. One direct extension of my research may
possibly involve further study of the Type III Secretion System and possible alternative
purposes of the protein transport system. A hypothetical scenario may include
recombination of the effector genes with therapeutic genes and manipulating the
secretion system as a drug delivery system. Other possible scenarios may include
directing expression of the secretion system and/or the target cell to expand the range of
the needle complex to transport proteins of interest. Research aimed at harnessing the
precision and seamless ease with which nature carries out biological procedures is akin to
summiting Mount Everest.
One aspect of my dissertation research that I was not able to address was the
inter-species interactions of Salmonella while in the gastrointestinal tract. With anywhere
between 300 and 1000 different species of bacteria comprising the flora of the large
intestine of the human, the interactions and communication occurring within this
environment seem extraordinarily vast. How a species is able to navigate and process
signals from its immediate environment remain hidden within its genetic code. For
example, SdiA is a quorum sensing regulator. Salmonella can activate this regulator by
detecting acyl homoserine lactones (AHL), however, Salmonella cannot synthesize AHL
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itself but detects AHL molecules from other microbes. Complex, sophisticated
mechanisms of sensing and interacting with the environment, such as this one, compose
an intricate web of communication that allows the proper function of the organ. A
disruption to this web can unbalance the environment and lead to malfunction, tissue
injury, even disease if equilibration is not restored. Quorum sensing is a possible area of
research that shows promise for inter- and intra-species communication. Broader areas of
research that are attractive include sociomicrobiology, systems biology, and metabolic
modeling.
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